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ABSTRACT 
 
Early detection and treatment of disease is paramount for improving human health 
and wellness. Micro-scale devices promote new opportunities for the rapid, cost-
effective, and accurate identification of altered biological states indicative of disease 
early-onset; these devices function at a scale more sensitive to numerous biological 
processes. The application of Micro-Electro-Mechanical Systems (MEMS) in biomedical 
settings has recently emerged and flourished over course of the last two decades, 
requiring a deep understanding of material biocompatibility, biosensing 
sensitively/selectively, biological constraints for artificial tissue/organ replacement, and 
the regulations in place to ensure device safety. Capitalizing on the inherent physical 
differences between cancerous and healthy cells, our ultra-thin silicone membrane 
enables earlier identification of bladder cancer—with a 70% recurrence rate. Building on 
this breakthrough, we have devised an array to multiplex this sample-analysis in real-time 
as well as expanding beyond bladder cancer. The introduction of new materials—with 
novel properties—to augment current and create innovative medical implants requires the 
careful analysis of material impact on cellular toxicity, mutagenicity, reactivity, and 
stability. Finally, the achievement of replacing defective biological systems with 
implanted artificial equivalents that must function within the same biological constraints, 
have consistent reliability, and ultimately show the promise of improving human health 
as demonstrated by our hydrogel check valve. The ongoing proliferation, expanding 
prevalence, and persistent improvement in MEMS devices through greater sensitivity, 
specificity, and integration with biological processes will undoubtedly bolster medical 
science with novel MEMS-based diagnostics and therapeutics.   
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CHAPTER 1 
INTRODUCTION 
1.1.  Micro Electro Mechanical Systems: the Rise of Micro-Technology 
In 1959 Nobel laureate, Richard Feynman, gave his legendary talk “There is 
Plenty of Room at the Bottom”, his overarching theme—what is possible when we can 
manipulate matter at the atomic scale (Feynman, 1959). He challenged his audience to 
imagine a car no longer than a millimeter or an encyclopedia written on the tip of a pen. 
In the hopes that these challenges would aspire new techniques for interacting with the 
microscopic world he even offered financial compensation to the first people who 
accomplished those goals. While one of these goals, the millimeter car, was achieved by 
conventional means by a highly skilled craftsman within a few months, the other was 
nearly forgotten until the development of electron beam lithography, nearly 15 years 
later. While these challenges did not spur the development of novel microscale 
manufacturing techniques as Dr. Feynman had intended. The development of the silicon 
processing industry effectively prompted both the integrated circuit and micro electro 
mechanical systems (MEMS)(Ko, 2007). Integrated circuitry required advanced 
understanding of the manipulation of silicon in order to dope, pattern, and etch surfaces 
to form transistors. Additionally, the scaling down of transistors with the advancement of 
batch fabrication techniques set the stage for further development within silicon 
processing.  
Silicon was initially thought to be a brittle and unwieldy mechanical material, 
however, in 1982 Petersen published a comprehensive review effectively negating that 
opinion and introducing the field of MEMS(Petersen, 1982). While the term MEMS is 
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not universal it generally refers to microscale devices fabricated using silicon processing 
techniques and includes micromachining, bulk, and surface machining. More specifically, 
techniques such as photolithography, thin-film deposition, chemical vapor deposition, 
thermal growth, wet etching, and deep reactive ion etching are integrated together to 
yield a wide variety of microscale sensors and actuators. MEMS devices operate using 
two underlying principles either an electrical input results in a physical action—an 
actuator—or a physical action results in an electrical output—a sensor (figure 1.1.). Often 
MEMS devices cannot be simply classified as either a sensor or an actuator, they often 
combine these concepts into a fully integrated system.  
MEMS devices have infiltrated numerous aspects of modern society, vehicles, 
projection systems, telecommunications, inkjet printing, and even biomedical 
applications (Eddy & Sparks, 1998; Ko, 2007; Takaki, Takenaka, Morimoto, Konuma, & 
Hirabayashi, 2012). The devices used in these industries typically have the smallest 
component range from 1 to 100 μm (figure 1.2.). When scaling devices from a macro—
typically meters long—to microscale the underlying physics shifts where capillary, 
stiction, and electrostatic forces have significantly more impact that inertial forces. This 
can be highly advantageous or lead to cautious device release techniques. Often capillary 
forces are large enough at the micro/nanoscale to allow for flow without external pump 
systems. Conversely, when releasing MEMS devices using liquids stiction often leads to 
the collapse of suspended structures such as cantilever beams, but this can be avoided 
with thoughtful preparation and the use of supercritical CO2 techniques. Furthermore, 
electrostatic actuation allows for the simple application of a voltage differential to induce 
the movement of a micro-mirror in optical MEMS. Coupled with the traditional 
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advantages seen in the semiconductor industry, low lost mass production and high yield 
MEMS devices have become a key feature in numerous modern technologies. 
1.2.  Biomedical MEMS: More Than the Sum of Its Parts 
Techniques commonly combined in biomedical MEMS were used as early as 
1967 by Carter et al. however, the field itself slowly gained traction and became 
independent in the early 1990s. This early work used thermally evaporated islands of 
palladium to explore cell spreading and cell membrane formation; capitalizing on 
traditional silicon processing techniques to understand biological concepts (Carter, 1967). 
This work was expanded upon using micro-fabricated groves to encourage directional 
cell growth (Brunette, 1986). Furthermore, the use of MEMS technology to understand 
cellular mechanics continued with the development of microscale cantilevers, 
microneedle arrays, and atomic force microscopy all examining cell-substrate interactions 
(Galbraith & Heetz, 1997; Małgorzata Lekka et al., 2012; Tan et al., 2003). The 
underlying principles of both micro-cantilevers and micro-needle arrays are very similar. 
When cells adhere to either they spread, ultimately bending the structures; given the 
known dimensions and flexibility of these substrates the resulting cell traction forces are 
easily derived. These early devices employed microfabrication techniques in order to 
examine cellular phenomenon. However, the field of biomedical MEMS has expanded 
beyond this initial iteration to not only examine cell-based mechanisms but explore bio-
sensing, organ modeling, DNA sequencing, disease diagnosis, and treatment.   
Often bio-sensing and disease diagnosis operate concurrently, where a biosensor 
detects a biomarker for a specific disease. The earliest MEMS chemical sensors, 1979, 
were gas chromatography systems using micro-fabricated fluidic systems to differentiate 
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and isolate various particles in gaseous form. In this work they hypothesize further 
applications toward implantable biomedical devices (Terry, Jerman, & Angell, 1979). 
This early suggestion of combining silicon fabrication techniques toward a biological 
sensor could be considered the first biomedical MEMS device. This pioneering research 
spurred the interdisciplinary combination of fluidics, microbiology, material science and 
engineering to generate a wide variety of biomedical MEMS devices in the form of lab-
on-a-chip, and micro total analysis systems (micro-TAS). Further development has led to 
resonators (film bulk acoustic (W. Xu, Appel, Chae, & Member, 2012), surface acoustic 
wave (Voiculescu & Nurashikin, 2012), quartz crystal (Marx, 2003), etc.) using mass or 
viscosity induced resonance change, optical (fluorescent (Hastie et al., 2013), light 
quenching (X. Sun et al., 2017)) induced changes, electrochemical (potentiometric (Qu, 
Xia, Bian, Sun, & Han, 2009))induced changed all selectively triggered by the presence 
of disease specific biomarkers (figure 1.3.).   
However, bio-sensing can also expand beyond disease diagnosis to provide 
physicians valuable data regarding blood oxygen levels, and intraocular or aortic 
pressure. Often these devices are either implantable or wearable. Devices measuring 
blood oxygen, have been in the medical field since the early 1940s however they were 
often unstable due to early light sources, use at the ear, and low accuracy (Millikan, 
1942). But with the advent of silicon processing and MEMS technology, these optical 
sensors were drastically improved and integrated into modern medicine. Currently, a 
similar optical technique is being pursued as a microscale implant (Fiala, Bingger, 
Foerstert, Heilmann, & Beyersdorti, 2010; Theodor et al., 2014). Interestingly, 
implantable intraocular pressure sensors were in development before the wide adoption 
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of silicon processing techniques, (figure 1.4.) (Collins, 1967). In 1967, Collins reported 
the development of diameter bubble tonometer (in the range 2 - 6 mm) and their success 
monitoring the intraocular pressure of rabbits for over a year (Collins, 1967). While these 
devices were fabricated using traditional, non-silicon processing based, techniques they 
did prompt the development and interest of the MEMS community inspiring the 
development of sensor embedded contact lenses for continuous intraocular pressure 
measurement (Cooper, Beale, & Constable, 1979; Greene & Gilman, 1974; M. Leonardi, 
Leuenberger, Bertrand, Bertsch, & Renaud, 2003; Matteo Leonardi, Pitchon, Bertsch, & 
Renaud, 2009), ultimately leading to device commercialization and approval by the 
United States Food and Drug Administration (FDA) (Dunbar, Shen, & Aref, 2017). 
While these devices are not traditionally considered bio-sensors they have become a 
subset of the biomedical MEMS field that is rapidly expanding into commercial 
applications. 
Another contribution to the biomedical MEMS field is the subfield of “organ-on-
a-chip”, similar to lab-on-a-chip concepts where cells can be studied on an individual 
basis, the organ-on-a-chip concept attempts to understand organ function in a well-
controlled in vitro model(Perestrelo, Águas, Rainer, & Forte, 2015). However, before 
organ-on-a-chip can be fully appreciated the development of polydimethylsiloxane 
(PDMS) based microfluidics must be introduced. PDMS is a transparent, non-toxic, 
biocompatible, gas permeable, polymer (Mata, Fleischman, & Roy, 2005), which is 
ubiquitous within biomedical MEMS. Generally, silicon wafers, post-micromachining, 
are used as PDMS molds to form microfluidic, pillar, or other complex structures (Duffy, 
Mcdonald, Schueller, & Whitesides, 1998; McDonald et al., 2000; Qin, Xia, & 
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Whitesides, 1996). PDMS microfluidics led to the development of the first organ-on-a-
chip, a lung-on-a-chip microsystem which induced cyclic mechanical strain on cells 
cultured within the device and modeled the impact of “breathing” airborne nanoparticles 
(Huh et al., 2010). Other organ-on-a-chip concepts include the modeling of arteries 
(Yasotharan, Pinto, Sled, Bolz, & Günther, 2015), kidney function (Wilmer et al., 2016), 
neurovascular systems (Alcendor et al., 2013), ocular drug treatments (Dodson, 
Echevarria, Li, Sappington, & Edd, 2016) and even modeling occlusion-based failure 
modes for hydrocephalus shunts (C. Harris, Pearson, Hadley, & Zhu, 2015). Generally, 
these projects aim to closely emulate physiological conditions to improve and reduce 
costs associated with drug screening or toxicology studies as well as expand 
understanding of complex organ systems and diseases.  
Microfluidics has become synonymous with biomedical MEMS and DNA 
sequencing was one of the early applications of microfluidics and has become a 
competitive commercial application. A commercial application of particular interest to 
the biomedical MEMS community is the techniques developed by BioNano Genomics 
(Hastie et al., 2013). They developed a micro/nano fluidic array designed to linearized 
pre-treated DNA fragments for visualization using fluorescent microscopy. This array is 
fabricated using an innovative shadow mask protocol to get pillars in a size gradient 
before the nanofluidic channels to effectively linearize the DNA strands (Cao, 
Tegenfeldt, Austin, & Chou, 2002; Cao, Yu, et al., 2002; Tegenfeldt et al., 2004). Other 
capillary electrophoresis techniques have integrated MEMS technology in fabricating 
their capillary channels (Harrison et al., 1993; Harrison, Manz, Fan, & Widmer, 1992; 
Simpson et al., 1998; J. Wang, Chatrathi, Tian, & Polsky, 2000) as well as the 
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development of nano-pore based sequencing which aims to “thread” DNA through a 1 to 
10 nm pore (Jain et al., 2018). An ionic current flows across the nano-pore, as a DNA 
strand is threaded through the pore the ionic current varies in response to the DNA 
sequence giving a specific change in current for each molecule (Jain et al., 2018). 
Microfluidics and therefore, biomedical MEMS is essential to modern DNA sequencing 
and has led to the development of numerous companies which rely upon capillary chips 
to provide valuable sequencing data. 
Biomedical MEMS therapeutics can generally be considered biosensors, however 
these biosensors aim to not only sense biological abnormalities but counteract them. This 
is demonstrated by the concept of an artificial pancreas—which has been partially 
achieved by continuous glucose monitoring systems—an implanted glucose sensing 
element detects an increase in glucose levels, this information is sent to an external 
insulin pump which then injects insulin to counteract the increased glucose levels. One 
such device being produced by Glysens Inc. is a wireless implantable continuous glucose 
monitoring system (Lucisano, Routh, Lin, & Gough, 2017). This device employs an array 
of platinum electrodes with corresponding silver/silver chloride reference electrodes to 
monitor the two-step enzymatic reaction of glucose oxidase and catalase which is 
compared to an oxygen sensing reference (Gough, Kumosa, Routh, Lin, & Lucisano, 
2010; Gough et al., 2003). This device is still in preliminary human trials and with 
continued success should be approved for continuous glucose monitoring. CardioMEMS 
Inc. employs a similar MEMS therapeutic based on one of the earliest MEMS devices, a 
membrane pressure sensor, strategically coupled to wireless technology and placed 
within the pulmonary artery to monitor blood pressure at that specific location (Potkay, 
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2008). This device has been approved by the FDA for human use, and provides life-
saving blood pressure information to physicians to detect worsening heart failure before 
the onset of symptoms allowing for the adjustment of medications to improve overall 
patient outcomes(Abraham et al., 2011) (Abraham et al., 2016). Other such implantable 
systems aim to integrate MEMS sensing technology such as hydrocephalus shunts 
coupled to MEMS intracranial pressure sensors (B. J. Kim et al., 2016) and nanoparticle 
drug delivery schemes (Meng & Sheybani, 2014) to directly provide medication at tumor 
sites. These devices are still in development; however, they have the potential to 
transform the medical industry and the regulation system surrounding it.  
1.3.  Medical Devices and the FDA: the Path to an Implantable Device 
In the early 1960s, intrauterine devices (IUDs) were under development in the 
United States and being used internationally. At this time, all medical devices ranging 
from contact lenses to surgical thread, were unregulated. IUDs were designed to induce 
foreign body response at the entrance to the uterus, which would in turn, reduce the rate 
of conception. It was hypothesized that a larger contact surface area would induce an 
even greater foreign body response and improve the overall device functionality, the 
Dalkon Shield was conceived. In 1971, this device was introduced to the general public 
and an aggressive marketing campaign lead to approximately 2.2 million devices sold in 
the United States and 1.7 million internationally (Roepke & Schaff, 2014).  
Within three years, studies were published citing the Dalkon Shield induced 
pelvic infections, septic abortions and death. In particular, noting that the material chosen 
for the string, effectively wicked bacteria into the uterus leading to an increased infection 
rate. In 1975 the FDA formally cited the string as a hazard (Roepke & Schaff, 2014) and 
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Dalkon Shields stopped being sold however no device recall was issued, and devices 
were still marketed internationally. Later studies determined that the Dalkon Shield 
induced at least ten thousand adverse events, ranging from pelvic infections to septic 
abortions, hysterectomies and at least 18 deaths (Roepke & Schaff, 2014). This directly 
led to an amendment of the Food, Drug, and Cosmetic Act of 1938, the Medical Device 
Regulation Act (Roepke & Schaff, 2014). This act established the classification of 
medical devices, the establishment of quality and functionality standards, and the 
requirement of pre-market approval depending on the classification of the device in 
question.  
This amendment, expanding the FDA regulatory power to include medical 
devices, radically changed the research and development of diagnostic and therapeutic 
devices. Prior to the 1976 medical device regulation act, implanted devices were simply 
researched, developed, and manufactured. Clinical trials were performed but not 
necessary to market and sell medical devices, even implantable devices. After the 
medical device regulation act passed all medical devices were classified based on the 
amount of risk associated with each device. Class 1 devices, such as dental floss, are the 
least risky devices and require the least amount of regulatory controls. Class 2 devices, 
such as condoms, require greater regulation to ensure device safety and effectiveness. 
Finally, class 3 devices, such as replacement heart valves, require the most regulation 
with devices being evaluated by the FDA before marketing.  
The ramifications of the medical device regulation act on the research and 
development of implantable medical devices has shifted the overall industry away from 
an academic environment towards the private sector. This shift has immensely altered a 
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device’s path to market. The FDA provides oversight of the medical device industry and 
the research required to implant devices in human patients. This necessitates a balance 
within the field of medical devices between academic research and industry device 
development. Rarely do academic researchers take a FDA regulated device from 
conception to market. A few exceptions to this rule are the biomedical MEMS companies 
CardioMEMS, which was the first implantable MEMS pressure sensor and BioNano 
Genomics, a micro / nano fluidics structure which enables the sequencing of long strands 
of DNA to better map genomes.  
1.4.  Material Biocompatibility: a Vital Step Towards Implantable Devices 
History has shown, time and again, the toxic effect of neglecting or 
misunderstanding material biocompatibility. Lead, mercy, silver, and even radium were 
found in occupational environments or commercial products leading to plumbism (lead), 
mad hatter’s disease (mercy), argyria (silver) and tumor growth (radium) (W. R. Lee, 
1968; Nowack, Krug, & Height, 2011; Tsatalis et al., 2017). These historical examples 
show the significance of evaluating material biocompatibility particularly when designing 
implantable devices. While there are numerous definitions of biocompatibility, the most 
widely excepted version states that a biocompatible material will induce a known and 
predicable biological response when tested. This can range from bio-inert materials such 
as cobalt-chrome alloys (Navarro, Michiardi, Castan, & Planell, 2008), which do not 
induce any biological response to bio-degradable materials, calcium phosphate, which 
induce a specific and well characterized biological response (Amini, Wallace, & 
Nukavarapu, 2011). Evaluating newly developed materials has become both a regulatory 
and scientific pursuit. Many regulatory agencies including the FDA and the 
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environmental protection agency enact public policy for both occupational and medicinal 
hazards which impact human exposure to toxic materials. Furthermore, biocompatibility 
is fascinating from a scientific perspective as the fields of nanomaterials and biology 
converge.     
Regulation and material biocompatibility couple in the form of standards. Both 
the International Standards Organization and the American Society for Testing and 
Materials have extensive biocompatibility determination protocols. These range from 
irritant testing to in vitro cell culture methods to subcutaneous or full implantation-based 
evaluations. This comprehensive look at material biocompatibility also encourages 
exploration of the mechanisms behind geno- or cytotoxicity, as well as the systemic 
examination of material degradation. This systemic approach investigates how a 
biological environment breaks down materials and the impact of degradation on 
secondary and tertiary organ systems such as the liver or kidneys, which typically filter 
small particles out of the blood stream. While the aforementioned standards provide a 
vital reference point, they are only the starting point of determining biocompatibility.  
Bulk materials normally known to be innocuous can become toxic when shape, 
size, or surface charge change (Jiang, Kim, Rutka, & Chan, 2008). Thus, the 
biocompatibility of nanoscale spheres, sheets, and tubes of various materials have been 
studied since the early 1970s (Couvreur, Tulkens, Roland, Trouet, & Speiser, 1977). For 
example despite being generally considered fully biocompatible gold can become toxic if 
in the form of less than 1.4 nm spherical particles (Alkilany & Murphy, 2010; Pan et al., 
2009). Similarly, conflicting reports of graphene and graphene oxide toxicity varies based 
on if the materials are fixed onto a substrate or allowed to float freely. In the first case 
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these materials are generally found to be biocompatible (G. Y. Chen, Pang, Hwang, 
Tuan, & Hu, 2012), however in the second case, these atomically thin sheets can 
effectively slice cell membranes making free floating graphene highly toxic (K.-h. Liao, 
Y.-s. Lin, C. W. Macosko, & C. L. Haynes, 2011). Nano-rods or tubes have also been 
investigated in terms of biocompatibility and found toxic in specific concentrations and 
dimensions (Pardo, Shuster-Meiseles, Levin-Zaidman, Rudich, & Rudich, 2014; Z. Sun 
et al., 2011). These distinctions have led to numerous conflicting reports which have only 
increased as some of the traditional methods of examining cultured cell viability have 
also been shown to be susceptible to interference by nanoparticles.  
Gross cellular viability is typically evaluated using commercially available 
reagents and protocols. These generally come in the form of colorimetric assays which 
respond to changes in cellular processes. Two of the most common are 
methylthiazolyldiphenyl-tetrazolium bromide (MTT) and water-soluble tetrazolium salt 
(WST-8). These assays rely on extracellular dehydrogenases to induce color change, 
however, both assays are susceptible to nanoparticle interference, particularly the MTT 
assay is often inaccurate if carbon based nanoparticles are being evaluated (Teo, Chng, 
Sofer, & Pumera, 2014). As these are somewhat indirect measures of cellular viability 
other commercial protocols rely on dual-fluorescent binding to either viable cell 
membranes (calcein-acetoxymethyl) or exposed cell nuclei (ethidium homodimer-1). 
Mechanistic cell viability can be examined by investigating apoptotic or necrotic triggers 
for cell death. One such mechanism is reactive oxygen species formation, in excess, 
reactive oxygen species can lead to either cell death pathway, however it is necessary in 
small amounts for cell signaling. After cellular viability is established more holistic 
13 
evaluations can be performed through the use of irritant, subcutaneous, and animal 
implantation testing. 
1.5.  Bioengineering: Devices to Replace Organs, a Hydrocephalus Example 
Diseases and ageing can be considered degradation of a biological system, from 
an engineering standpoint we can replace this degradation with an improved non-
biological implant, simply replace an arthritic hip with a prosthesis. In some cases these 
replacements can even improve upon the natural design (Lechler & Lilja, 2008). Other 
situations spur from disease, requiring devices to bypass defective regions or replace 
organ function. This will be exemplified by the case of hydrocephalus shunts and 
alternative treatments which will be addressed in more detail in chapter 5. In order to 
design a treatment, we must first understand the biological context surrounding the 
disease state. In the case of hydrocephalus there is a flaw in the cerebrospinal fluid (CSF) 
flow pathway which leads to an accumulation of CSF within the brain. This flaw, in 
certain types of hydrocephalus, is in the arachnoid granulations—biological one-way 
valves which regulate CSF flow from the intracranial space into the superior sagittal 
sinus. Historically this disease was treated by simply drilling a hole in the skull and 
draining excess CSF (Aschoff, Kremer, Hashemi, & Kunze, 1999; Khamlichi, 1998). At 
the time there was not a sterile method of performing this technique and mortality rates 
are assumed to be near 100% until the 1890s. This method of simply removing excess 
fluid became the norm until the 1950s when implantable shunt systems were developed 
to regulate CSF flow internally.  
In the case of hydrocephalus, the disease state is straightforward, this allows for 
system modeling. There has been much progress in understanding the complex fluid 
14 
dynamic behavior within the intracranial space.  The greatest insights have been provided 
by computational models derived from magnetic resonance imaging (MRI) scans of both 
healthy controls and hydrocephalic patients.  These models reveal the complex interplay 
of fluid across the brain, the ventricles, and subarachnoid space (Buishas, Gould, & 
Linninger, 2014; Andreas A. Linninger, Sweetman, & Penn, 2009; Andreas A Linninger 
et al., 2005; Sweetman & Xenos, 2011). While these computational models provide 
important insights, it has remained difficult to apply these models to physical device 
testing conditions for the interface of the subarachnoid space and superior sagittal sinus. 
Several research groups have pursued bench top phantom models of CSF flow. These 
models are gross depictions of intracranial fluids dynamics. Of these physical models, the 
most advanced and physiologically relevant has come from the ‘Interface Group’ based 
out of the University of Zurich. Their initial attempt was a life size model of the 
intracranial space that includes the brain, ventricles, and subarachnoid space(Bottan, 
Poulikakos, & Kurtcuoglu, 2012; Bottan et al., 2013). This model has been used to mimic 
the intracranial pressures observed in healthy individuals, the CSF flow pattern produced 
by the ventricles and the resulting localized normal pressure in the subarachnoid space 
(Bottan et al., 2012; Bottan et al., 2013). Their more recent bench top model more closely 
mimics the effects of body orientation on hydrocephalus shunt system performance, 
particularly investigating cases of over drainage (Gehlen, Kurtcuoglu, & Daners, 2016). 
In addition to modeling, we can also examine healthy tissues to understand the design 
parameters vital to restoring CSF flow.  
After the system is fully understood, a design to replace the malfunctioning organ, 
in this case, arachnoid granulations can be pursued. Accurately replicating the function of 
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arachnoid granulations is the ultimate goal of treating hydrocephalus. The flow-pressure 
characteristics for functioning arachnoid granulations resembles the current-voltage 
characteristics of diodes with a forward current applied. When the ‘threshold voltage’ or 
cracking pressure is reached, flow through the arachnoid granulation starts and when that 
flow is reversed the AG remains closed with little to no leakage. Grzybowski et al. 
reported this unidirectional flow of extracted arachnoid granulations. High fluidic 
conductivity was measured when following the natural CSF flow pathway from the 
subarachnoid space to the superior sagittal sinus. While reversing the natural flow 
pathway, a very low fluidic conductivity corresponding to near zero flow was measured 
(Grzybowski, Holman, Katz, & Lubow, 2006). With this understanding of arachnoid 
granulation function, the development of devices which mimic that function can begin.  
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Figure 1.1.  Schematic diagram of sensing and actuating concepts.  MEMS devices 
are generally in the form of either sensors or actuators and can be integrated into systems 
which feature both sensing and actuating components. A physical action results in an 
electrical output—a sensor—while an electrical input results in a physical action—
actuator.  
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Figure 1.2.  Scanning electron microscopy images of a variety of MEMS devices 
fabricated at Sandia National Laboratories.  These MEMS devices exemplify the 
complex structures that can be achieved using MEMS fabrication techniques.   
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Figure 1.3.  Schematic of biosensing concepts.  Many biosensors have a similar overall 
concept. A receptors for specific disease indicating biomarkers are immobilized on the 
surface of a transducer. When a patient sample which contains the targeted biomarkers is 
placed on the transducer a change in the device parameters occurs. This change is then 
amplified and processed.  
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Figure 1.4.  Advancement of Intraocular Pressure Sensing. In 1967 Collins published 
a bubble tonometer as a wireless passive implantable intraocular pressure sensor with the 
smallest device having a diameter of 2 mm. These devices were fabricated without silicon 
processing techniques and implanted in rabbits for up to 1 year with issue (Collins, 1967). 
With the advent of MEMS technology intraocular pressure measurement were refined 
leading to soft contact lenses with passive and active strain gauges and wireless powering 
and communication capable through the antenna (Matteo Leonardi et al., 2009). In 2016, 
the FDA announced device approval for SENSIMED Inc. Triggerfish contact lenses with 
embedded sensing capabilities(Dunbar et al., 2017). 
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CHAPTER 2 
RAPID BLADDER CANCER CELL DETECTION FROM CLINICAL URINE 
SAMPLES USING AN ULTRA-THIN SILICONE MEMBRANE 
Reproduced with permission from Royal Society of Chemistry. Appel J.H., Ren H., Sin 
M.L., Liao J.C., Chae J. “Rapid bladder cancer cell detection from clinical urine samples 
using an ultra-thin silicone membrane” Analyst. ePub 2015 Nov 9, DOI: 
10.1039/C5AN01616A 
2.1.  Abstract  
Early detection of initial onset, as well as recurrence, of cancer is paramount for 
improved patient prognosis and human health. Cancer screening is enhanced by rapid 
differentiation of cancerous from noncancerous cells which employs the inherent 
differences in biophysical properties. Our preliminary testing demonstrates that cell-line 
derived bladder cancer cells deform our <30 nm silicone membrane within an hour and 
induce visually distinct wrinkle patterns while cell-line derived non-cancerous cells fail 
to induce these wrinkle patterns. Herein, we report a platform for the rapid detection of 
cancerous cells from human clinical urine samples. We performed a blinded study with 
cells extracted from the urine of human patients suspected to have bladder cancer 
alongside healthy controls. Wrinkle patterns were induced specifically by the five cancer 
patient samples within 12 hours and not by the healthy controls. These results were 
independently validated by the standard diagnostic techniques cystoscopy and cytology. 
Thus, our ultra-thin membrane approach for cancer diagnosis appears as accurate as 
standard diagnostic methods while vastly more rapid, less invasive, and requiring limited 
expertise.  
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2.2.  Introduction 
Bladder cancer is the fifth most common cancer in the United States with 
estimated 74,000 new cases in 2015 (Society, 2015). Since bladder cancer has a high rate 
of new tumor formation, a recurrence rate of up to 70%, lifelong surveillance is necessary 
as often as every 3 months which incurs significant expense and time commitment 
(Aldousari & Kassouf, 2010). Current bladder cancer diagnosis is based on an invasive 
endoscopy procedure called cystoscopy followed by biopsy of suspect lesions for 
histological examination. To compensate for cystoscopy which lacks sensitivity for low 
grade flat carcinoma (Aldousari & Kassouf, 2010) urine cytology—the microscopic 
examination of naturally exfoliated and expelled urothelial cells in the urine—is widely 
employed alongside cystoscopy. While highly specific (>95%), urine cytology has low 
(~20%) and moderate (~60%) sensitivity for low and high grade cancers, respectively 
(Tomasini & Konety, 2013). As a consequence of this low sensitivity for early cancer 
detection, there are strong interests to develop urine-based diagnostics to complement and 
overcome shortcomings of cytology and cystoscopy. The majority of efforts have focused 
on developing molecular diagnostics based on cancer-associated genetic changes, as well 
as alterations in RNA and protein expression (Cheung, Sahai, Billia, Dasgupta, & Khan, 
2013). While several molecular assays are commercially available, significant 
shortcomings remain, which include diagnostic sensitivity and excessive cost, precluding 
widespread adaptation (Cheung et al., 2013). 
Quantitative measurement of cellular biophysical properties of cancerous and 
non-cancerous cells represents a promising alternative strategy for cancer diagnosis, 
given the intrinsic difference in cytoskeleton flexibility, morphology and stiffness of 
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cancerous from non-cancerous cells. Young’s modulus, a measurement of cellular 
stiffness, is particularly promising for cancerous cell detection (Y. Chen et al., 2014; P. 
Li et al., 2015). For bladder cancer, Lekka et al. determined that cancerous cell lines 
HU456, T24, and BC3726 had an average Young’s modulus of 0.8 kPa compared with 
10.0 kPa for non-cancerous cell lines HU609 and HCU29 (M Lekka et al., 1999). For 
oral cancer, cells extracted from patients with oral squamous cell carcinoma were three-
fold more flexible than non-cancerous cells from healthy donors (Remmerbach et al., 
2009). Tan et al. also compared the translocation time, related to cytoskeleton flexibility 
of T24, cell-line derived human bladder cancer cells, and immortalized non-cancerous 
human urothelial cells (Tan et al., 2003). These cell types were passed through a micro 
pore via an applied electric field. The non-cancerous urothelial cells had an order of 
magnitude increase in translocation time when compared to their cancerous counterparts 
(M Lekka et al., 1999). Thus scanning force microscopy, optical stretching and 
translocation via applied electric field have all shown significant differences in the 
biophysical properties of cancerous and non-cancerous cells. The differences in Young’s 
modulus and cytoskeleton flexibility between cancerous and non-cancerous cells are in 
part due to another biophysical property, the cellular traction forces applied to an in vitro 
surface. Cell traction forces can be visualized using micro-pillar structures (Tan et al., 
2003) or silicone membranes (A. Harris, Wild, & Stopak, 1980; Ilyas et al., 2014). Li et 
al. employed a silicon nano-pillar structure to determine that cancerous human Hela cells 
exerted 20% greater cell traction force when compared to non-cancerous fibroblasts 
harvested from neonatal rat liver (Z. Li et al., 2009). The application of micro-pillars as a 
diagnostic device requires highly-optimized fabrication techniques and sophisticated 
31 
analytical methodologies. Although these methods all show distinct differences between 
the biophysical properties of cancerous and non-cancerous cells, they have not been 
employed for cancer cell detection.  
Here we report a high-throughput strategy capable of differentiating bladder 
cancer cells from non-cancerous cells based on their respective cellular traction forces. 
Our method requires minimal sample preparation, does not demand highly-trained 
personnel for data interpretation, and only involves an inexpensive low-power 
microscope. Our approach leverages an ultra-thin, <30 nm, silicone membrane to 
visualize the distinct cell traction forces of bladder cancer cells. Our ultra-thin silicone 
membrane is deformed exclusively by cancerous cells, producing distinct wrinkle 
patterns compared to non-cancerous cells (J. Appel, Sin, Liao, & Chae, 2014). In this 
study, we examined the underlying mechanism for ultra-thin membrane deformation 
exclusively by cancerous bladder cells by manipulation and visualization of focal 
adhesion proteins. Furthermore, clinical validation of our cancer detection strategy was 
performed.  A double-blind study was performed using urine collected from five 
individuals presenting cancer-like symptoms.  And within 12 hours, of sample collection 
cancer cells present in all five patient urine samples generated wrinkle patterns. Our 
technique circumvents traditionally complex, costly, and invasive instrumentation for 
bladder cancer screening and detection as well as may be applied for the detection of 
additional cancers.   
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2.3.  Materials and Methods 
Device fabrication. Ultra-thin silicone membranes were formed by adding ~45μL of 
12,500 cP viscosity liquid silicone (Brookfield Engineering Laboratories) to a 15 mm by 
0.5 mm glass depression slide (Ted Pella, Inc.). The uppermost layer of silicone was 
cross-linked by inverting the slide over a flame for 5 to 10 seconds. The cell culture 
chamber was formed by attaching a 1.9 cm diameter by 2.54 cm height section of sterile 
PVC with vacuum grease to the glass slide (figure 2.1.(a)) (A. Harris et al., 1980). In 
some experiments, ultra-thin silicone membrane surfaces were modified by the addition 
of 10 μg fibronectin (BD Biosciences) in 1X PBS, incubated at room temperature for 1 
hour, aspirated and membranes washed three times with 1X PBS. 
Cell culture. RT4 is an established bladder cell-line derived from low grade human 
transitional cell papilloma. T24 is derived from high grade human transitional cell 
carcinoma. HEK293f is a transformed human embryonic kidney cell-line that served as 
non-cancerous controls to simulate epithelial cells found in non-cancerous urine samples. 
RT4 and T24 cells were grown in McCoy’s 5A modified media (Life Technologies) and 
HEK293f cells were grown in Eagle’s minimum essential medium (ATCC). Media was 
supplemented with 10% fetal bovine serum (FBS, Life Technologies), and 1X 
penicillin/streptomycin (Sigma-Aldrich). Cells were maintained in a 5% CO2 
environment at 37˚C. 
Cell-line sample preparation. Cells at 80% confluency were trypsinized (Invitrogen) or 
incubated with cell dissociation buffer (Life Technologies) for 5 min at 37˚C and washed 
with media supplemented with 10% FBS. Approximately 5x105 cells were applied to 
each device and incubated in culture media with at 5% CO2 at 37˚C at various time 
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intervals and then inspected via microscopy (figure 2.2.). For simulating clinical samples 
with hematuria, 5x105 white blood cells from buffy coat (Innovative Research) were 
applied to the ultra-thin membrane prior to applying RT4 or HEK293f. For urine pH 
effect, artificial urine (Spectrum Laboratories Inc.) or clarified aggregated donor urine 
samples were supplemented with 10% FBS and the pH adjusted with hydrochloric acid. 
Patient and healthy donor sample preparation. Five patient urine samples were obtained 
from men ages 53 to 89 undergoing trans-urethral resection of bladder tumor (TURBT) 
(Babjuk, 2009) at VA Palo Alto Health Care System and a sixth urine sample was 
collected from a healthy female donor control with no family history of bladder cancer 
and only a single grandparent with lung cancer likely linked to smoking, age 26. 
Informed consent was obtained from all patients. Cells present in the urine were pelleted 
by centrifugation at 300 x gravity, washed twice with 1X PBS and re-suspended in 
McCoy’s 5A modified media supplemented with 10% FBS prior to application to the 
ultra-thin silicone membrane. 
Data analysis. The pattern generated when a cluster or individual cell deforms the ultra-
thin membrane is defined as a wrinkle pattern. Wrinkle patterns consist of a number of 
wrinkles which have various lengths. In addition, wrinkle patterns were quantified by 
measuring the number and length of each wrinkle following addition of cells to ultra-thin 
silicone membrane. 
Fluorescent imaging. F-actin was fluorescently labeled with Alexa Fluor 488 Phalloidin 
phallotoxin (Life Technologies) following the manufacturer’s instructions. Briefly,T24 
and HEK293f cells were pre-incubated on the ultra-thin silicone membrane for 24 hours 
were fixed with 4% paraformaldehyde in 1X PBS for 10 min at 37˚C, washed twice with 
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1X PBS, permeabilized with 0.1% Triton X-100 in 1X PBS for 10 min at 37˚C and 
washed twice with 1X PBS. The permeabilized cells were incubated with fluorescent 
Alexa Fluor 488 Phalloidin phallotoxin for 20 min at room temperature, washed twice 
with 1X PBS and visualized under a confocal microscope (Nikon Eclipse TE2000-U). 
Fluorescent intensity traces were measured using Image J and the data was binned for 
every 4 values. 
2.4.  Results and Discussion 
Ultra-thin membrane characterization. Previous reports have focused on the visualization 
of cell locomotion with cancerous cells on uncharacterized silicone membranes of 
various thicknesses (A. Harris et al., 1980; Ilyas et al., 2014; Pelham & Wang, 1999).  
We characterized our silicone membrane by applying a minute droplet of water to the 
surface (J. Appel et al., 2014; Huang et al., 2007). The approximately 0.5 µL of water on 
the surface of membrane induced a radial wrinkle pattern (figure 2.1. (b)). From the 
wrinkle pattern, the thickness of the membrane was calculated to be approximately 28 
nm. A predictive estimation of the wavelength, amplitude and number of wrinkles is 
included in the supplemental materials (Cerda & Mahadevan, 2003). 
Wrinkle pattern from cell-line derived cancerous cells. We compared the time and extent 
of membrane wrinkle formation generated by cell-line derived low grade bladder 
papillary carcinoma RT4 cells, used as a control (figure 2.3. (a)). In this study, we 
evaluated and compared RT4 cells to a cell-line derived high grade bladder carcinoma 
T24 cells. Cancer grades represent tumor severity and the likelihood of metastasis within 
human patients. Approximately 5x105 RT4 or T24 cells were applied to our silicone 
membrane, and distinct wrinkles were generated by both within 4 hours (figure 2.3. (a) & 
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(b)). To elucidate the onset of wrinkle pattern formation for cancerous RT4 and T24 cells, 
a time-lapse experiment was performed for 4-, 6-, and 8-hour incubation periods; as 
opposed to a time-lapse experiment using only RT4 cells at 18-, 20-, and 22-hour 
incubation periods. Both the RT4 cells (figure 2.4. (a)-(d)) and the T24 cells (figure 2.4. 
(e)-(h)) induced wrinkle patterns after 4 hours of incubation. By examining the aggregate 
number of wrinkle patterns generated at various time intervals, we found a positive 
correlation between the number of wrinkles patterns and the time of incubation (figure 
2.3. (c)). In contrast, the number of individual wrinkles and the length of these wrinkles, 
which comprise individual wrinkle patterns, showed little direct correlation with the 
incubation time (figure 2.3. (d)). For example, RT4 cells generated on average 5.7 
individual wrinkles after 8 hours, while T24 cells generate 2.3 individual wrinkles. Our 
representative cancerous cells generated wrinkle patterns as early as four hours and the 
wrinkle patterns formed persisted over the entire length of observation.  
To ensure that selectively cancerous cells induce wrinkle pattern formation on our 
ultra-thin silicone membrane, we used a non-cancerous healthy control of cell-line human 
kidney epithelial (HEK293f) cells. HEK293f cells were chosen due to the high degree of 
similarity between the epithelial cells found in the kidney and the bladder cavity. 
Approximately 5x105 HEK293f cells were applied to our membrane. HEK293f cells 
failed to generate discernable wrinkle patterns or individual wrinkles (figure 2.4. (i)-(l)) 
after extended incubation period of 24 hours. Thus cell-induced wrinkle pattern formation 
was specific to the cancerous cell-line derived cells we tested and not shared with non-
cancerous cell-line derived cells. 
36 
To better replicate potential clinical testing of human patient samples, we placed 
cell-line derived cancerous cells in modified urine environments. This simulates the 
conditions in which cells could not be readily extracted from human urine by 
centrifugation and instead whole urine samples would be applied to the membrane, such 
as in developing nations. We incubated cancerous RT4 or T24 cells on ultra-thin 
membranes in human (figure 2.5. (b)) or artificial (figure 2.5. (a)) urine at pH varying 
from 5 to 7, within the typical range of human urine (Wright et al., 2005). To sustain the 
cancerous cell-line derived RT4 or T24 cells for extended device testing, we 
supplemented the clarified—by centrifugation—human or artificial urine with 10 % fetal 
bovine serum. As expected, the cancerous RT4 and T24 cells retained the ability to 
induce membrane deformation and generated wrinkle patterns in both human and 
artificial urine, across all tested pH values. The aggregate number of wrinkle patterns was 
not a function of the type of urine, human or artificial, or the pH value (figure 2.5.). Thus 
the inherent biophysical properties differences responsible for cancer-specific wrinkle 
formation is not affected by the urine or changes in pH. 
Wrinkle patterns from a mixture of cancerous and non-cancerous cells. First we 
examined the capacity of cancerous RT4 cells to generate wrinkle patterns in the 
presence of non-cancerous cells HEK293f and buffy coat cells. Buffy coat is the fraction 
of blood that is comprised principally of white blood cells. White blood cells are often 
found in clinical patient urine, as one of the primary symptoms of bladder cancer is 
hematuria or blood within the urine. We examined the attributes of the present wrinkle 
patterns, i.e. number and length of wrinkles within each wrinkle pattern. Quantitation of 
the number of wrinkles within a wrinkle pattern was performed by serially counting the 
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number of wrinkles generated by each cluster of cancerous cells or an individual 
cancerous cell. The length of each wrinkle within a wrinkle pattern was measured relative 
to the diameter of a cell, approximated as 20 µm. No apparent correlation was observed 
between mixture ratio and these wrinkle pattern attributes. However, a strong inverse 
trend was found between the overall number of wrinkle patterns and mixture ratio (figure 
2.6. (a) & (b)). Wrinkle patterns are defined as the culmination of wrinkles generated by a 
cluster or individual cell within a discrete span separate from other cells and induced 
membrane deformations of the ultra-thin membrane. Therefore by examining the overall 
number of wrinkle patterns we can better represent clinical use of the ultra-thin 
membrane diagnosis platform, because a clinician would only need to determine if 
wrinkle patterns are present. Clinical patient urine samples are composed of a very small 
population of cancerous cells in the presence of an overwhelmingly non-cancerous cell 
population. Therefore increasing the number of non-cancerous cells better simulates 
clinical samples.  Additional experimentation by varying mixture ratios to deplete the 
population of cancerous cells is necessary to define a true threshold for detection. 
However, in clinical applications approximations of the actual number of cancer cells 
present in a urine sample could be determined based on the number of wrinkle patterns 
present. 
Clinical urine sample testing. To validate the ultra-thin membrane as a detection tool of 
human patient bladder cancer, we obtained urine samples from five individuals 
presenting cancer-like symptoms. All patients were male ages 53 to 89. And four of the 
five patients were being treated for a recurrence of bladder cancer. Additionally, two of 
the five patients reported a history of smoking. Urine samples were collected during a 
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trans-urethral resection of bladder tumor (TURBT) procedure, which is the current 
standard for bladder cancer diagnosis (Cheung et al., 2013). Also a control urine sample 
was collected via urination from a female healthy donor, age 26, with no family history 
of bladder cancer and only a single grandparent with lung cancer likely linked to 
smoking. Cells were extracted from all urine samples, washed and applied to the ultra-
thin membrane.   
Following 12 hours of incubation, wrinkle patterns were observed in the five 
bladder cancer patient samples (figure 2.7.). Additionally, the healthy donor control cells 
failed to generate wrinkle patterns even after an extended incubation period of 24 hours 
(figure 2.4. (m)-(p)). The actual number of wrinkle patterns observed (table 2.1.), ranging 
from 1 to 5, corresponds to less than a wrinkle pattern per ultra-thin membrane. This 
indicates that despite the low concentration of cancer cells, practical use of the ultra-thin 
membrane for cancer detection is well within the membrane detection limit which is 
dependent on the concentration of cancer cells in the urine sample.  
Standard diagnosis method, TURBT confirmed the five patients had bladder 
cancer. TURBT is performed by an endoscopic examination of the bladder interior and 
upon finding abnormal tissue extracting a small biopsy. This biopsy is then sent for 
examination by an experienced cytopathologist. As a complementary diagnosis method 
urine cytology is performed. This method is also dependent on an experienced 
cytopathologist to extract cells from urine and examine for abnormal cellular structure. 
For the purposes of this experiment patients had previously undergone either cytology, 
cystoscopy or both before TURBT (table 2.1.). However, the patient prognosis was 
unknown until after analysis of the biopsy collected during TURBT. Interestingly, of the 
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five patient samples, two—patient #2 and #3—demonstrated false negative results, i.e. 
negative for malignancy, by standard urine cytology, while generating an accurate 
positive result on our ultra-thin silicone membrane. Thus, initial validation of our ultra-
thing silicone membrane demonstrates that this platform is highly sensitive and accurate 
for the detection of human patient bladder cancer from urine samples. 
Validation of cell traction forces that generate wrinkle patterns. To further characterize 
and identify the working mechanism of wrinkle pattern formation, we varied the cell 
transfer method. T24 cells were removed from culture dishes by the addition of the 
protease trypsin or a cell dissociation buffer applied to our ultra-thin silicone membranes 
and imaged at 1 hour intervals for a total of four hours. While the T24 cells treated with 
the protease trypsin required three hours for initial wrinkle pattern formation, the T24 
cells treated with the cell dissociation buffer generated wrinkles within a single hour 
(figure 2.8. (a)). The initial transfer method relied on trypsin which physically severs the 
focal adhesion proteins on the surface of the cell which must be regrown prior to cell-
induced wrinkle formation. By shifting to a cell dissociation buffer, the focal adhesion 
proteins remain intact which dramatically reduces the time for wrinkle pattern formation, 
by negating regeneration of the adhesion protein. Therefore, we were able to decrease the 
time for cancerous cell wrinkle formation to one hour post cell addition to our membrane 
by changing the cell transfer method. 
In an effort to make wrinkle patterns generated by RT4 cells more distinctive, we 
investigated a means of increasing the individual attributes of wrinkle patterns. We 
attempted to increase the individual number and length of wrinkles within a wrinkle 
pattern by coating the membrane with fibronectin, a cellular adhesion promoting protein. 
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However, the average number and average length of wrinkles did not significantly vary 
with the addition of fibronectin (figure 2.8. (b)). Treatment of our ultra-thin silicone 
membrane surface with fibronectin failed to significantly affect the induction of 
membrane wrinkles measured by the number or length of individual wrinkles within 
wrinkle patterns.  
To validate that cancerous cells are mechanically capable of generating sufficient 
strain, to induce deformation of our ultra-thin silicone membrane to produce wrinkle 
patterns. The observed strain induced deformation of our membrane by cancerous RT4 
cells was compared to previously reported strain generated by cancerous cells (Z. Li et 
al., 2009). Water droplet calibration of the membrane approximated 0.1% to 0.4% 
lumped strain (figure 2.1. (b)). This correlates well with lump strain we derived from a 
study of cell traction forces of on a polydimethylsiloxane micro-pillar structure, which 
was estimated to be 0.5% lump strain (Z. Li et al., 2009). We derived this lump strain by 
averaging the strain generated by the displacement of each micro-pillar. This averaged 
strain was then normalized by the ratio between the surface area of each pillar in contact 
with the cell over the total area of the cell (Z. Li et al., 2009). Additionally, a positive 
correlation between cellular traction force and metastatic potential of cancerous cells has 
been reported (Koch, Munster, Bonakdar, Butler, & Fabry, 2012; Kraning-rush, Califano, 
& Reinhart-king, 2012). Thus the strain, as measured by cell traction forces, visualized 
by the number of wrinkles within a wrinkle pattern could be applied for discerning the 
grade of a cancer cell. 
Cell traction forces are responsible for inducing strain in the ultra-thin membrane; 
these forces are dependent on focal adhesion proteins. Filamentous-actin (f-actin), a focal 
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adhesion protein integral for cell shape, relocates to the edges of the cell for cell 
locomotion and spreading upon a surface (D.-h. Kim et al., 2012). Thus a focus of f-actin 
indicates that a force is being applied by the cell to an external surface (D.-h. Kim et al., 
2012). To verify that the cytoskeleton of cancerous cells induces membrane deformation 
and generates wrinkle patterns in our ultra-thin silicone membrane, we fluorescently 
stained the f-actin with philotoxin. Philotoxin specifically binds to f-actin and the co-
localization of philotoxin adjacent to wrinkle patterns would strongly support cellular 
adhesion being responsible for the membrane deformation.  Following 24 hours of 
incubation of on the membrane, we fixed and stained T24 or HEK293f cells to visualize 
the localization of f-actin relative to wrinkle formation. Individual (figure 2.9. (a) – (c)) 
and clusters (figure 2.9. (d) – (f)) of T24 cells both generated two wrinkles, and more 
importantly the fluorescently stained f-actin co–localized with these wrinkles. Within an 
individual T24 cell, a locus of f-actin co-localized with the origins of wrinkles produced 
by the cell (figure 2.9. (c)). An intensity trace of fluorescence adjacent to the wrinkle 
showed a dramatic increase in fluorescence, and thus and increased presence f-actin at 
this location (figure 2.10. (a) & (c)). In contrast, individual and clusters of HEK293f cells 
failed to generate wrinkles (figure 2.9. (g) – (l)), did not have any discernable locus of f-
actin, and the fluorescent intensity trace showed homogeneous intensity within the cell 
(figure 2.10. (b) & (d)). The co-localization of an f-actin locus immediately adjacent to 
the origin of the wrinkle patterns generated by cancerous T24 cells, along with the lack 
an f-actin locus in non-cancerous HEK293f cells, which fail to induce wrinkling, supports 
the cytoskeleton of cancerous cells inducing the deformation of the membrane and 
ultimately for wrinkle pattern formation. This indicates that the cytoskeleton of the T24 
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cell is exerting a force on the ultra-thin membrane which does induce wrinkle pattern 
formation. Thus the underlying mechanism for membrane wrinkle formation appears 
dependent on f-actin foci and thus the cytoskeleton. While ancillary for clinical 
evaluation of patient samples, examining the underlying mechanism for wrinkle pattern 
formation gives insight into the inherent biophysical differences behind wrinkle pattern 
formation.   
2.5.  Conclusion 
 Results from our double-blind study on human patients with bladder cancer-like 
symptoms show that cells extracted from clinical urine samples can selectively deform 
our ultra-thin silicone membrane and generate wrinkle patterns. While cells extracted 
from the urine of healthy donors fail to sufficiently induce wrinkle formation. We 
confirm via manipulation and labeling of cellular adhesion proteins that this innate 
difference in the ability to generate wrinkle patterns in our membrane is in part due to the 
unique biophysical properties of cancerous cells from healthy counter parts. Thus, our 
ultra-thin silicone membrane has the potential to be developed into a simple, yet cost 
effective tool to discern the presence of bladder cancer from cells present in urine 
samples. Furthermore, our methodology can be applied toward the diagnosis of additional 
cancers where cells are easily obtained or naturally expelled, e.g. lung cancer detection 
through analysis of sputum. Moreover, our cancer diagnosis approach is highly amenable 
to developing nations where conventional diagnosis is cost-prohibitive and impedes 
continuous monitoring for initial onset and recurrences of cancer. Our device leverages 
inherent biophysical properties of cancerous cells for non-invasive, improved early 
detection and continuous surveillance for the recurrence of cancer. 
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Figure 2.1. Membrane Characterization and Fabrication (a) Membrane fabrication 
method, beginning with high viscosity liquid silicone in a concave glass slide, then the 
top layer of the liquid silicone is cross-linked via heat forming the ultra-thin membrane; a 
culture vessel is then applied creating a water-tight seal with the glass slide. (b) 
Membrane characterization method, using water droplets to determine membrane 
thickness. 
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Figure 2.2. Overall imaging set-up for the observation of wrinkle patterns generated 
by cancerous cells. Inset shows 6 devices which each contain ultra-thin membranes, 
culture media and cells.  
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Figure 2.3. Wrinkle Pattern Formation and Analysis (a) Approximately 75 RT4 cells 
generating a wrinkle pattern which consists of 12 wrinkles with an average length of 75 
μm, after more than 24 hours. (b) Approximately 150 T24 cells generating 3 wrinkle 
patterns, the top pattern consists of 5 wrinkles with an average length of 50 μm, the 
middle pattern consists of 13 wrinkles with an average length of 60 μm, and the bottom 
pattern consists of 3 wrinkles with an average length of 80 μm, after more than 24 hours. 
(c) Plot of the total number of wrinkle patterns generated by each cell type: RT4, T24, 
HEK293f, and Healthy Donor, at each time interval. (d) Plot showing the average 
attributes of a wrinkle pattern generated by either RT4 or T24 cells at each time interval, 
n=4. All scale bars are 20 μm. 
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Figure 2.4.  Time Lapse of Wrinkle Pattern Formation in All Cell Types (a) – (d) 
RT4 cells at 0, 4, 6, & 8 hours, generating 3 wrinkle patterns after 4 hours, (e) – (h) T24 
cells at  0, 4, 6, & 8 hours, generating 2 wrinkle patterns after 4 hours, (i) – (l) HEK293f 
cells at  0, 4, 8, & 24 hours, no wrinkle patterns are present, (m) – (p) healthy donor 
epithelial cells at  0, 4, 8, & 24 hours, no wrinkle patterns are present. All scale bars are 
20 μm. 
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Figure 2.5.  Analysis of Wrinkle Patterns in Urine of Varying pH Levels (a) Plot of 
the number of wrinkle patterns generated by either RT4 or T24 cells in artificial urine at 
various pH levels. (b) Plot of the number of wrinkle patterns generated by either RT4 or 
T24 cells in a mix of purified healthy donor urine at various pH levels.  
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Figure 2.6. Wrinkle Patterns in Mixed Cell Populations (a)Plot of the number of 
wrinkle patterns generated by cancerous cells in each mixture ratio (RT4:HEK293f) (b) 
Plot of the number of wrinkle patterns generated by cancerous cells in each mixture ratio 
(RT4:HEK293f:buffy coat).  
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Figure 2.7.  Wrinkle Patterns Formed by Clinical Patient Samples (a) wrinkle pattern 
generated by patient 1 after 24 hours (b) wrinkle pattern generated by patient 2 after 24 
hours (c) wrinkle pattern generated by patient 5 after 12 hours (d) wrinkle pattern 
generated by patient 3 after 24 hours (e) wrinkle pattern generated by patient 4 after 12 
hours (f) no wrinkle patterns generated by healthy donor control. All scale bars are 20 
µm. 
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Figure 2.8.  Comparing Cell Transfer Methods and Adhesion Promoting Proteins 
(a) Plot of the total number of wrinkle patterns generated over time after being transferred 
using either trypsin or a cell dissociation buffer, n=3. (b) Plot of the average attributes of 
a wrinkle pattern generated by RT4 cells after 12 hours in either unmodified devices or 
devices coated with fibronectin. 
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Figure 2.9. Fluorescent Staining of F-Actin in Cells Which Generate Wrinkle 
Patterns (a) A fixed individual T24 cell generating a wrinkle pattern consisting of 2 
wrinkles with an average length of 40 μm. (b) Fluorescently stained F-actin in the T24 
cell from (a). (c) Merge of (a) & (b) where both images are 60% opaque.  (d) A fixed 
cluster of T24 cells generating a wrinkle pattern consisting of 2 wrinkles with an average 
length of 60 μm. (e) Fluorescently stained F-actin in the T24 cell cluster from (d). (f) 
Merge of (d) & (e) where both images are 60% opaque. (g) A fixed individual HEK293f 
cell. (h) Fluorescently stained F-actin in the HEK293f cell from (g). (i) Merge of (g) & 
(h) where both images are 60% opaque. (j) A fixed cluster of HEK293f cells. (k) 
Fluorescently stained F-actin in the cluster of HEK293f cells from (j). (l) Merge of (j) & 
(k) where both images are 60% opaque. All cells were fixed after more than 12 hours. All 
scale bars are 20 μm. 
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Figure 2.10. Fluorescent Intensity Traces Comparing F-Actin in T24 & HEK293f 
Cells (a) & (b) are intensity traces which follow the dashed white lines in (c) and (d) 
respectively, (c) is a fluorescently stained T24 cell and (d) is a fluorescently stained 
HEK293f cell. Arrows indicate spikes the corresponding areas responsible for spikes in 
the intensity traces. All scale bars are 20 μm. 
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Table 2.1. Comparison of Clinical Patient Diagnosis Methods and Wrinkle Pattern 
Detection. Relevant patient information including sex, age, prior cystoscopy and 
cytology results as well as the observation of wrinkle pattern formation and the aggregate 
number of wrinkle patterns for each patient sample if applicable. 
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CHAPTER 3 
ULTRA-THIN ELASTOMER MEMBRANE ARRAY WRINKLING FOR 
BLADDER CANCER DIAGNOSIS 
Reproduced with permission from IEEE. Appel, J.H., Sin, M.L.Y., Liao, J.C., Chae, J. 
“Ultra-thin elastomer membrane array wrinkling for bladder cancer diagnosis” Micro 
Electro Mechanical Systems (MEMS), 2016 IEEE 29th International Conference, 24-28 
Jan. 2016 
3.1. Abstract 
We report an ultra-thin silicone membrane array to simultaneously discern the 
presence of cancerous cells in as many as 16 samples from multiple individuals. This 
high throughput parallel array relies on the intrinsic and specific biophysical properties of 
cancerous cells to induce deformation, or ‘wrinkling’ on the arrayed membrane. In 
contrast, non-cancerous cells fail to generate these membrane wrinkles. We evaluated an 
initial pilot study to test clinical urine samples from patients at a high risk for bladder 
cancer. We also expanded the functionality of the ultra-thin membrane array beyond 
bladder cancer toward the screening of cervical cancer. This screening array has the 
potential to be deployed at the point-of-care to improve throughput compared to 
sequential analysis by individual membranes and may be able to enhance reliability and 
accuracy by coordinating controls for false results concurrently. 
3.2. Introduction 
There are 17,986 active cytopathologists in the United States of America as of 
2010 (Robboy et al., 2009). These experts must sequentially and tediously examine a 
myriad of patient samples, looking for cellular morphological features which may 
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indicate the presence of cancer or other diseases. While the workflow has been partially 
automated through the use of image assisted screening (Biscotti et al., 2005), full 
automation is challenged by the complex nature of the samples and the reliance upon 
these experts for interpretation of patient samples.  
Cytopathogists exclusively examine the morphology of cells extracted from 
patient samples. However the inherent biophysical properties of cells may in fact aid 
cytopathologists in process of discerning cancerous cells from non-cancerous cells. It has 
been found that cancerous cells are in general more flexible, malleable, and stretchable. 
This was as shown by significant differences in cytoskeletal Young’s modulus, fluidity, 
and cell traction forces (Coughlin et al., 2013; M Lekka et al., 1999; Z. Li et al., 2009).  
Various methods were used to analyze these differences. For example, Lekka et al. 
measured Young’s modulus using scanning force microscopy. They found that the 
Young’s modulus of bladder cancer cells were approximately an order of magnitude 
smaller, 0.4 ± 0.3 to 1.4 ± 0.7 Pa, compared to normal, non-cancerous cells, 10 ± 4.6 to 
12.9 ± 4.8 Pa (M Lekka et al., 1999). Cellular fluidity was measured by Coughlin et al. 
using cellular adhesion to magnetic beads. They found a correlation between metastatic 
capabilities and cellular fluidity, where the more “fluid-like” a cell is the greater the 
likelihood of metastasis (Coughlin et al., 2013). Cell traction forces were measured by Li 
et al. using a silicon nanowire array. Three cell types were applied to the array such that 
cell traction forces could be compared between non-cancerous and cancerous cells. They 
found that cancerous cells generate between 22 and 50 % more cell traction force, 2.8 to 
3.5 µN, than non-cancerous cells, 2.25 µN (Z. Li et al., 2009). These findings support the 
observation that cancerous cells have significantly different biophysical properties from 
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non-cancerous cells.  Along with standard techniques the differences in biophysical 
properties can be used to assist cytopathologists in identifying cancerous cells. 
Additionally these differences may allow for, and even aid in the development of 
additional automation techniques within the field of cytopathology.  
Cell adhesion and migration upon a surface generates traction forces, which 
induce easily indefinable localized deformation on a sufficiently thin membrane. Harris et 
al. reported a silicone membrane that visualized the traction forces generated by chick 
heart fibroblast cells during cellular locomotion. They approximated these forces, using a 
flexible weighted probe, to be in the range of 10 nN/µm of leading cell edge (A. Harris et 
al., 1980). Further refinement of this approach has included embedding fluorescent beads 
within the membrane to aid in tracking cell locomotion (Oliver, Dembo, & Jacobson, 
1995) and modeling to extract the magnitude and direction of cellular traction forces 
(Dembo, Oliver, Ishihara, & Jacobson, 1996).   
We presented a proof of concept study on a visualization platform to distinguish 
the presence of cancerous cells in mixed cell populations based on the inherent 
biophysical differences between cancerous and non-cancerous cells (J. H. Appel, Ren, 
Sin, Liao, & Chae, 2016). This visualization platform consisted of an ultra-thin silicone 
membrane which both cancerous and non-cancerous cells adhered to however cancerous 
cells exclusively deformed the membrane generating wrinkle patterns. This preliminary 
work established the working mechanisms of the visualization platform and determined 
its effectiveness; however a substantial challenge remains unsolved: only one patient 
sample could be evaluated at a time.   
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Herein, we present an ultra-thin membrane array for use within the field of 
cytopathology for the simultaneous analysis of clinical urine samples extracted from 
individuals with a history of bladder cancer. Additionally we expand beyond screening 
for bladder cancer into applications for cervical cancer, where cytopathology is the 
cornerstone of the screening protocol. By capitalizing on the inherent biophysical 
differences between cancerous and non-cancerous cells our ultra-thin membrane array 
offers cytopathogists a highly paralleled, high throughput screening tool for bladder 
cancer and potentially cervical cancer. 
3.3. Materials and Methods 
Visualization array platform – fabrication. Fabrication of the ultra-thin silicone 
membrane begins by coating a glass slide with high viscosity (12,500 cP) liquid silicone, 
as shown in figure 3.1. (a). Then we invert the slide over a low flame (Bunsen burner) 
effectively cross-linking the polymer chains in the liquid silicone forming a thin crust or 
membrane. After sanitizing (20% ethanol) the  
microtiter insert, i.e. array structure, we apply a layer of vacuum grease to it and press it 
onto the glass slide creating a water tight seal in the area surrounding the membrane, 
figure 3.1. (b). 
Visualization array platform – characterization. The physical properties of our ultra-thin 
silicone membrane were characterized with the addition of minute water droplets to its 
surface (J. H. Appel et al., 2016). Briefly, water droplets applied to a sufficiently thin 
membrane induce deformation in that membrane which results in a sinusoidal wrinkle 
pattern. Using the equations derived by Cerda  et al. (Cerda & Mahadevan, 2003) we can 
derive the thickness of the membrane based on the number of individual wrinkles present 
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in each wrinkle pattern. The thickness of each membrane was determined from the 
observed number of wrinkles caused by the addition of water droplets to the membrane 
(figure 3.2. (a)). Due to inconsistences in the fabrication of the large scale membrane and 
the application of the microtiter insert, membrane thickness varies (figure 3.2. (b)). 
However the average thickness is 89 nm with a standard deviation of 30. Despite this 
inherent variation, membranes were still well within an acceptable thickness range. 
Cell culture. T24 transitional bladder cancer cells were grown in McCoy’s 5A modified 
media (Life Technologies Corp. 16600-082) supplemented with 10% fetal bovine serum 
(FBS Life Technologies Corp. 10082-139) and 1X penicillin/ streptomycin (Sigma-
Aldrich Co. P4333-20ML) and incubated at 37 ˚C in humidity and 5% CO2. Human 
embryonic kidney cells, HEK293f and cervical cancer cells, HeLa, were grown in eagle’s 
minimum essential medium (ATCC 30-2003) supplemented with 10% FBS and 1X 
penicillin/streptomycin incubated at 37˚C in humidity and 5% CO2. 
Sample preparation – cell-line derived. Cells at 80% confluency were trypsinized for 5 
min at 37˚C, inactivated with 10% FBS, pelted by centrifugation at 300 times gravity for 
5 min, re-suspended in culture media and approximately 3x104 cells, at a concentration of 
150 cells/µL, were applied to each sub-section of the array. Cells were imaged after 24 
hours exposure to the ultra-thin membrane array using a confocal microscope (Nikon 
Eclipse TE2000-U).   
Sample preparation – patient samples. Clinical samples were collected via urination from 
3 individuals undergoing routine screening for bladder cancer due to a history of bladder 
cancer. These samples were spun at 300 times gravity, washed twice with 1X PBS and 
re-suspended in culture media prior to application to the ultra-thin silicone membrane 
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array. After 24 hours exposure to the ultra-thin membrane wells were examined using a 
standard inverted microscope for the presence of wrinkle patterns.   
3.4. Results and Discussion 
Following the characterization of our ultra-thin silicone membrane array, we 
explored our device for discerning the presence of cancerous cells. We separately 
incubated 3x104 T24 bladder cancer cells, HeLa cells derived from cervical cancer, and 
human embryonic kidney epithelial HEK293f cells on our membranes. After 24 hours of 
incubation on the ultra-thin membrane array T24 cells (figure 3.3. (a)), and HeLa cells 
(figure 3.3. (b)) both generate easily discernable wrinkle patterns, which each consist of 4 
and 5 individual wrinkles and an average wrinkle length of 62.5 µm and 48 µm, 
respectively. However, 24 hours following adhesion to the membrane, HEK293f cells 
failed to induce any wrinkles (figure 3.3. (c)). Both bladder and cervical cancerous cells 
exerted significantly stronger adhesion forces on the membrane array when compared to 
non-cancerous cells.     
 Consistency within the array structure is vital to discerning capabilities 
particularly in the field of cytopathology, where each cell must be examined individually 
for the presence of cancer. Therefore we evaluate the ultra-thin silicone membrane array 
in terms of individual wells and the full array. We evaluated a full array using T24 
bladder cancer cells and found that 50% of the wells identified the presence of cancerous 
cells via wrinkle pattern generation. This inconsistency directly justifies having an array 
of ultra-thin membranes   to incorporate redundancy, and consequently reduce the 
potential for false negatives. There are two distinguishing features of wrinkle patterns, the 
number of wrinkles and the length of those wrinkles. Within this array an average 
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number and length of wrinkles of 2.88 and 39.88 µm, respectively, demonstrating 
consistent wrinkle pattern formation in the array (figure 3.4. (a)).  
 Additionally we aim to expand beyond the exclusive discerning of bladder cancer, 
such that we can screen patients for many varieties of cancers using the ultra-thin 
membrane array. Therefore we have examined the adhesion of cervical cancer cells on 
the ultra-thin silicone membrane array and found that 81% of wells identified the 
presence of cervical cancer via wrinkle pattern formation. Within this array an average 
number and length of wrinkles of 3.08 and 68 µm, respectively, demonstrating consistent 
wrinkle pattern formation in the array (figure 3.4. (b)).  
 The number and length of wrinkles are allow us to approximate the forces 
generated by the cell to form wrinkle patterns. However these parameters are of little 
significance in application because the mere presence of a single wrinkle pattern indicates 
that a cancerous cell has been discerned and that further investigation should be 
undertaken. Therefore the ultra-thin membrane theoretically has the potential to 
complement and improve the field of cytopathology. Specifically the arrayed version of 
the ultra-thin membrane can greatly enhance the through-put of cytopathology, due to the 
simplification of cancer cell screening and the multiplexing of patient samples. 
 With institutional review board approval, urine samples were collected from three 
patients with a history of bladder cancer, who were undergoing routine surveillance, 
bladder endoscopy (cystoscopy) and cytology (Cheung et al., 2013) at the VA Palo Alto 
Health Care System (table 3.1.). These patient urine samples were introduced to and 
analyzed on a single membrane array, occupying 2, 2, and 4 wells, respectively based on 
sample volume and the concentration of cells in each sample. After 24 hours exposure to 
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the ultra-thin membrane array the cells extracted from these patient samples failed to 
generate membrane wrinkles. The absence of wrinkle pattern formation suggests that 
cancerous cells were not present in the urine samples. Indeed, our membrane array results 
were confirmed by cystoscopy which was normal in two patients and the third individual 
had an insignificant, benign lesion. Our membrane array has simultaneously screened 
three patients and has the potential to concurrently screen 16 patients. 
 This demonstrates that our ultra-thin membrane array putatively does not generate 
false positive results. With further testing of patient samples we can continue to verify 
this trend and insure that true positives are indeed detected. Most importantly this initial 
clinical testing shows that non-cancerous cells extracted from patient urine samples, 
which included fragmented cells and bacteria do not interfere with the screening for 
bladder cancer. This implies that the ultra-thin membrane array truly has the potential to 
successfully screen patient samples in cytopathologic situations and with further 
adaption, such as robotic microscopy and image recognition, the potential to fully 
automate the field of cytopathology. 
3.5. Conclusions 
We present that an ultra-thin silicone membrane array which can serve as a 
cytopathology tool, i.e. a visualization platform to differentiate between cancerous and 
non-cancerous cells based on membrane wrinkle patterns. Our system exploits a 
fundamental difference in cell biophysical properties, ensuring the accuracy and 
sensitivity for cancer detection. It also vastly improves throughput as up to 16 patient 
samples can be tested and analyzed concurrently.  With further development this high 
through-put ultra-thin membrane array has the potential to automate the field of 
64 
cytopathology reducing the time and cost associated with cancer screening and vastly 
improving patient prognosis through rapid screening and early diagnosis. 
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Figure 3.1.  Schematic and photo of the visualization array platform.  (a) Coat a glass 
slide with 12,500 cps liquid silicone. Cross-link the polymer using heat to form the ultra-
thin membrane. Using vacuum grease adhere the array structure, i.e. microtiter insert, to 
the glass slide and fill wells with culture media and cells. (b) The completed ultra-thin 
silicone membrane 8x2 array, with a well footprint of 6.5 x 6.5 x 3.2 mm3. 
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Figure 3.2.  Characterization of the visualization array platform. (a) Exemplary ultra-
thin membrane well during characterization via water droplet. (b) Variation in membrane 
thickness, average thickness delineated by the red line and standard deviation by the gray 
rectangle.  
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Figure 3.3.  Various wrinkle patterns or lack thereof generated by cell-line derived 
samples. (a) Wrinkle pattern generated by bladder cancer cells. (b) Wrinkle pattern 
generated by cervical cancer cells, (dashed enclosures indicate the cluster of cells which 
generate each wrinkle pattern and arrows indicate the individual wrinkles). (c) Non-
cancerous (HEK293f) cells after 24 hours of incubation: Pre-existing wrinkles formed 
during membrane fabrication are NOT distorted by the adhesion of HEK293f. 
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Figure 3.4.  Characterization of wrinkle patterns within an array. (a) Characterizing 
wrinkle patterns generated in a single array by T24 cancerous bladder cells after 24 hours 
in contact with the ultra-thin membrane, 8 wrinkle patterns were observed. (b) 
Characterizing wrinkle patterns generated in a single array by HeLa cancerous cervical 
cells after 24 hours in contact with the ultra-thin membrane, 24 wrinkle patterns were 
observed. 
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Sex/Age Endoscopy Cytology Diagnosis Wrinkle Patterns 
M/57 Normal Negative Normal No 
M/82 Normal Negative Normal No 
M/68 Insignificant lesion Negative Normal No 
 
 
Table 3.1.  Comparison of clinical diagnosis methods and wrinkle pattern detection. 
Relevant patient information including sex, age, prior cystoscopy and cytology results as 
well as array-based ultra-thin membrane diagnosis via observation of wrinkle pattern 
formation. 
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CHAPTER 4 
LOW CYTOTOXICITY AND GENOTOXICITY OF TWO-DIMENSIONAL MOS2 
AND WS2 
Reproduced with permission from American Chemical Society. Appel, J.H., Li, D.O., 
Podlevsky, J.D., Green, A.A., Wang Q.H., Chae J., “Low Cytotoxicity and Genotoxicity 
of Two-Dimensional MoS2 and WS2” ACS Biomaterials Science and Engineering, 2016, 
2 (3) 361-367 DOI 10.1021/acsbiomaterials.5b00467 
4.1. Abstract  
 Atomically thin transition-metal dichalcogenides (TMDs) have attracted 
considerable interest because of their unique combination of properties, including 
photoluminescence, high lubricity, flexibility, and catalytic activity. These unique 
properties suggest future uses for TMDs in medical applications such as orthodontics, 
endoscopy, and optogenetics. However, few studies thus far have investigated the 
biocompatibility of mechanically exfoliated and chemical vapor deposition (CVD)-grown 
pristine two-dimensional TMDs. Here, we evaluate pristine molybdenum disulfide 
(MoS2) and tungsten disulfide (WS2) in a series of biocompatibility tests, including live-
dead cell assays, reactive oxygen species (ROS) generation assays, and direct assessment 
of cellular morphology of TMD-exposed human epithelial kidney cells (HEK293f). 
Genotoxicity and genetic mutagenesis were also evaluated for these materials via the 
Ames-Fluctuation test with the bacterial strain S. typhimurium TA100. Scanning electron 
microscopy of cultured HEK293f cells in direct contact with MoS2 and WS2 showed no 
impact on cell morphology. HEK293f cell viability, evaluated by both live-dead 
fluorescence labeling to detect acute toxicity and ROS to monitor for apoptosis, was 
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unaffected by these materials. Exposure of bacterial cells to these TMDs failed to 
generate genetic mutation. Together, these findings demonstrate that neither 
mechanically exfoliated nor CVD-grown TMDs are deleterious to cellular viability or 
induce genetic defects. Thus these TMDs appear biocompatible for future application in 
medical devices.  
4.2. Introduction 
Transition metal dichalcogenides (TMDs) are a class of layered materials with the 
general formula MX2, where M represents a transition metal (Mo, W, Ta, Nb, etc.) and X 
represents a chalcogen (S, Se, Te). In the past few years, studies of atomically-thin 2D 
TMDs have expanded rapidly due to their impressive electrical, optical, and structural 
properties (Neto & Novoselov, 2011; M. Xu, Liang, Shi, & Chen, 2013). Semiconducting 
TMDs like MoS2 and WS2, have band gaps that transition from indirect to direct when 
their thicknesses are reduced from bulk to monolayer (Mak, Lee, Hone, Shan, & Heinz, 
2010; Song, Hu, & Zeng, 2013). Monolayer TMDs have been integrated into field-effect 
transistors which possess both high on/off current ratios and reasonable carrier mobilities 
(Q. H. Wang, Kalantar-Zadeh, Kis, Coleman, & Strano, 2012), good photoluminescence 
at room temperature (He et al., 2015), and high elastic strength (Castellanos-Gomez et al., 
2012). In the biomedical fields, fullerene-like TMD nanoparticles have been used for 
their tribological properties to reduce friction in numerous applications (R Tenne, 2003; 
Reshef Tenne, 2013; R. Tenne & Seifert, 2009). Solid lubricants containing fullerene-like 
WS2 were commercialized in 2008 (Reshef Tenne & Redlich, 2010). In orthodontia, WS2 
nanoparticles have been embedded in the stainless steel wires used to manipulate teeth, 
and Redlich et al. reported that incorporation of WS2 reduced overall frictional force in 
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this application by 54% (Redlich et al., 2008). Additional tribological applications 
include gels impregnated with WS2 or MoS2 nanoparticles to reduce friction in 
endoscopic procedures9 and bone tissue engineering (Lalwani et al., 2013).  
Despite existing biomedical applications using TMDs and the still-emerging 
applications of 2D TMDs, few investigations into the biocompatibility and toxicity of 
TMDs have been performed. So far, initial in vivo toxicology tests of fullerene-like WS2 
nanoparticles on mammals found no toxic effects (Redlich et al., 2008). Cytotoxicity 
examinations of fullerene-like MoS2 and WS2 on human cell-lines, salivary gland cells 
(Goldman et al., 2015) and A549 (Wu et al., 2011), found that they are non-toxic to cells 
as cell viability remained high after prolonged exposure to TMDs (Goldman et al., 2015; 
Wu et al., 2011). Recently, Teo et al. reported the varying cytotoxicity of lithiated forms 
of WS2, MoS2 and WSe2, which are chemically and electronically different from their 
pristine forms. In that study, human lung carcinoma epithelial cells (A549) were used to 
show that lithiated WS2 and MoS2 are extremely biocompatible while lithiated WSe2 
caused dose-dependent toxicological effects (Teo et al., 2014). Although lithiated TMDs 
are being explored as vectors for drug delivery and photothermal therapy (Liu et al., 
2014), these chemically treated TMDs possess metallic conductivity and thus lack the 
highly desirable photoluminescent properties of pristine TMDs. These fundamental 
differences in the electronic and optical properties of lithiated and pristine TMDs suggest 
that these phases may also interact with biological systems in very different ways. 
Moreover, future medical application of TMDs in areas like optogenetics will require 
pristine materials that retain their fluorescence. Consequently, there is an urgent need for 
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systematic and in-depth biocompatibility and toxicity studies on pristine, 
unfunctionalized TMDs. 
Here we report a detailed study examining the biocompatibility of pristine two-
dimensional WS2 and MoS2 toward human epithelial kidney cells, HEK293f. Studying 
the impact of fine particulates on HEK293f is particularly relevant because particulates of 
this kind have the tendency to accumulate in the kidneys (Ballestri et al., 2001; Takenaka 
et al., 2001). We examine the effects of culturing HEK293f cells directly in contact with 
large flakes, or sheets, of thin TMDs using a fluorescent calcein-AM/ethidium 
homodimer-1 live/dead assay and a fluorogenic probe designed to measure reactive 
oxygen species (ROS) in live cells. We also examined the potential bacterial 
mutagenicity of these 2D nanoparticulates by performing an Ames-Fluctuation assay 
using S. typhimurium TA100. Our comprehensive set of experiments show that 2D and 
particulate forms of TMDs exhibit very low cytotoxicity and genotoxicity effects and are 
thus attractive materials for future biomedical applications. 
4.3. Materials and Methods 
TMD synthesis – flakes and sheets. Crystalline flakes of TMDs were exfoliated from bulk 
crystals of WS2 (2D Semiconductors) and MoS2 (SPI Supplies) using the scotch tape 
method onto substrates (silicon wafers with 300 nm SiO2 and oxygen plasma treated 
PDMS). Large area sheets of MoS2 were synthesized using chemical vapor deposition 
onto SiO2/Si substrates that were cleaned by sonication in acetone for 5 min, in 
isopropanol for 5 min, and oxygen plasma for 10 min. The precursors were 15 mg 
molybdenum trioxide, MoO3 (≥99.5%, Sigma-Aldrich) and 100 mg sulfur, S (99.5%, 
Alfa Aesar). Growth occurred in a 1-inch diameter tube furnace (Lindberg). The MoO3 
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precursor was placed in the center of the heating zone in a quartz boat with the SiO2/Si 
substrate placed above it, face down. The S was placed at the edge of the heating zone. 
The CVD growth occurred at vacuum pressure (1.37 Torr) with 300 sccm Ar gas flow. 
The furnace was first heated to 650°C at a rate of 16°C/min, held at 650°C for 30 min, 
and rapidly cooled to room temperature. The mechanically exfoliated and CVD-grown 
samples were used for the live-dead assay and the SEM assay. 
TMD synthesis – particulates. TMD particulates were prepared from bulk WS2, bulk 
MoS2, and CVD-grown MoS2 by ultrasonic bath sonication. Fragments of bulk MoS2 and 
WS2 weighed, placed in sterile water or tissue culture media and submerged in an 
ultrasonic bath until only the ultra-fine particulates remain. CVD particulates were 
prepared by sonicating the MoS2-covered SiO2/Si substrates until all traces of MoS2 were 
removed from substrates.  The concentrated particulate suspensions were then diluted to 
obtain the various concentrations used in the assays. 
TMD characterization - Raman spectroscopy, scanning electron microscopy, surface 
charge and fluorescence. Mechanically exfoliated WS2, mechanically exfoliated MoS2, 
and CVD-grown MoS2 were all deposited on Si wafers with a 300 nm SiO2 capping 
layer. Raman spectroscopy was conducted using a WITec Alpha300R Confocal Raman 
Imaging System with 532 nm excitation, 300 µW laser power and a 100X objective lens.  
 TMD particulates were analyzed using SEM. A small amount of the liquid 
containing each type of fragment was placed onto a glass slide and left until completely 
evaporated. Then the glass slide was sputter coated with a layer of gold, approximately 
10 nm thick, and imaged with a scanning electron microscope (Hitachi S-4700-II).  
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 TMD particulates were evaluated for surface charges using a Zetasizer Nano ZS 
to evaluate zeta potential with a mechanically exfoliated MoS2 particulate sample at a 
concentration of 1 mg/mL.  TMD particulates were also evaluated for fluorescence 
(Horiba Nanolog) using a range of excitation wavelengths (400 nm to 600 nm) and 
emission wavelengths (600 nm to 800 nm). These measurements did not reveal any 
photoluminescence peaks attributable to MoS2. 
Cell culture. HEK293f cells (Invitrogen) were grown in Eagle’s minimum essential 
medium (EMEM) (ATCC). Media was supplemented with 10% fetal bovine serum (FBS, 
Life Technologies), and 1X penicillin/streptomycin (Sigma-Aldrich). Cells were 
maintained in a 5% CO2 environment at 37˚C. Cells at 80% confluency were trypsinized 
(Invitrogen) for 1 min at 37˚C and washed with media supplemented with 10% FBS. 
Approximately 105 cells were applied to each device and incubated in culture media with 
at 5% CO2 at 37˚C. 
Live-dead assay. Mechanically exfoliated tungsten disulfide, mechanically exfoliated 
molybdenum disulfide, CVD-grown molybdenum disulfide, silver, epoxy, graphite, and 
plain PDMS were prepared for the live / dead assay and all were placed on oxygen 
plasma cleaned PDMS substrates. Gold and silver were sputter coated onto the PDMS 
substrate and epoxy was mixed then spread onto the PDMS. HEK293f cells were cultured 
on 24 subsections of each material and incubated at 37˚C in a 5% CO2 environment for 4, 
12, 24 and 48 hours. After the desired time interval, samples were placed in a solution 
containing 2 μM calcein AM and 4 μM ethidium homodimer-1 (Life Technologies, 
viability/cytotoxicity kit for mammalian cells) and incubated at room temperature for 30 
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minutes, without exposure to light, then imaged under a fluorescent confocal microscope 
(Nikon Eclipse TE2000-U).  
For the live-dead assay a minimum of 10 technical replicates of each material 
were examined at every time interval. The numbers of live and dead cells in direct 
contact with the material was tallied, and then the average percent of live cells was 
quantified from all samples. The standard error was also quantified for each time and 
material. 
Cell morphology scanning electron microscopy preparation and imaging. Large flakes 
and sheets of each TMD was used for SEM imaging, all control materials from the live-
dead assay were also imaged. HEK293f cells were cultured in direct contact with the all 
materials for 24 hours. Then cells were washed 3 times in PBS, fixed in 4% 
paraformaldehyde in 1X PBS for 10 min at 37˚C, and washed twice with 1X PBS. 
Samples were then dehydrated serially, 10 minute transfers through 50, 60, 70, 80, 90, 
and 100 % ethanol. Then devices were sputter coated with a layer of gold, approximately 
10 nm thick, and imaged using a scanning electron microscope (Hitachi S-4700-II).   
Reactive oxygen species (ROS) assay. TMD particulates and copper particulates were 
used for the ROS assay. Solid copper (8.33 mg) was placed in 1 mL of EMEM 
supplemented with 10 % FBS, then placed in an ultrasonic bath for seven minutes to 
degrade the copper into particles. HEK293f cells were cultured to 80% confluency then 
exposed to various concentrations of each TMD particulate (100, 10, 1, 0.1 μg/mL) and 
copper (8.33 mg/mL) for 1, 8 and 24 hours. After each time interval the proprietary ROS 
fluorogenic probe (Molecular Probes, CellROX) was added to a concentration of 5 
μg/mL to the culture well and incubated for 30 minutes at 37 ˚C, then the culture well 
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was washed 3 times with 1X PBS to remove any unbound ROS fluorogenic probe and 
visualized under a fluorescent confocal microscope (Nikon Eclipse TE2000-U) using 
485/520 (nm) excitation/emission.  
For the ROS assay a minimum of 8 technical replicates of each TMD 
concentration, the positive copper control and the untreated negative control were 
examined at each exposure time. Fluorescence intensity was measured using ImageJ 
software, and then intensity was averaged over the full area of the image. Standard error 
was calculated by determining the standard deviation between each technical replicate 
and dividing by the square root of the number of technical replicates. Significance was 
calculated by determining the chi-squared value, in comparison to the copper-positive 
control, and then using a standard chi-squared distribution table to determine p-value. 
Ames-fluctuation test – reverse mutation. TMD particulates were used for the Ames-
Fluctuation test of reverse mutation. Particulates were sterilized using heat and 70% 
ethanol. The Ames-Fluctuation assay (Environmental Bio-Detection Products Inc.) was 
performed according to the manufacturer’s instructions. Briefly, the reaction mixture 
containing Davis-Mingioli salts, D-glucose, bromocresol purple, D-Biotin and L-histidine 
was mixed with the particulates and purified water to concentrations of 100, 10, 1 and 0.1 
μg/mL. TA100 bacteria, grown overnight to turbidity, was added to each concentration of 
TMD particulates. Each mixture was then distributed into 20 wells of a 96 well plate, 
along with the positive control: mutation generating sodium azide and negative control: 
untreated bacteria. All plates were placed in a sealed bag, to prevent evaporation, and 
incubated at 37˚C for 3 to 6 days. Results were read by visual inspection of each well, 
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with yellow or turbid wells considered positive for bacterial mutation and purple wells 
considered negative for mutation.  
For the Ames-Fluctuation reverse mutation assay 20 wells of each sample and the 
controls were prepared. The number of yellow and purple wells, meaning positive and 
negative for mutation, respectively, were tallied and the percentage of revertants was 
calculated. Significance was calculated by determining the chi squared value, in 
comparison to the sodium azide-positive control, and then using a standard chi squared 
distribution table to determine p-value. 
4.4. Results 
Synthesis and characterization of WS2 and MoS2. Thin flakes of WS2 and MoS2 were 
prepared from bulk crystalline samples by mechanical exfoliation using adhesive tape. 
We examined mechanically exfoliated WS2 (ME-WS2) and MoS2 (ME-MoS2) flakes that 
were around 8 – 10 μm in diameter (Figure 4.1. (a)-(b)). Large area, continuous, thin 
films of bilayer, trilayer and few-layer MoS2 were also synthesized using CVD (CVD-
MoS2) (Figure 4.1. (c)). Material size is of particular concern for cell viability because 
HEK293f cells are known to take up foreign materials via endocytosis (Osman et al., 
2012). However, it is unlikely that the flakes or sheets of WS2 and MoS2 will permeate a 
cell membrane because they are of similar size to that of the cell (typically 20 µm in 
diameter). Additionally materials larger than 100 nm in diameter typically do not undergo 
endocytosis by HEK293f cells (Jiang et al., 2008; Osman et al., 2012). 
We characterized these TMD samples using Raman spectroscopy to estimate their 
thicknesses, as shown in Figures 4.1. (d), 4.1. (e), and 4.1. (f). Characteristic peaks 
corresponding to the A1g and E12g phonons for MoS2 and WS2 are observed, and the 
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difference between them are used to identify the layer numbers. For our ME-WS2 flakes 
the observed peak difference of 70.2 cm-1 corresponds to 5 to 8 atomic layers (Gutierrez 
et al., 2013; J. G. Song et al., 2013); for our ME-MoS2 the difference of 21.9 cm-1 
corresponds to 3 to 4 atomic layers (C. Lee et al., 2010); for our CVD-MoS2 the 
difference of 20.7 cm-1 corresponds to 2 to 3 atomic layers (C. Lee et al., 2010). Material 
thickness is of particular concern for cell viability: if that material becomes “free 
floating” it may slice the cell membrane and induce death, as shown by Liao et al. for 
monolayer graphene and graphene oxide which slice red blood cells (K. H. Liao, Y. S. 
Lin, C. W. MacOsko, & C. L. Haynes, 2011). We avoid this issue by placing each 
material onto an inert substrate like polydimethylsiloxane (PDMS) or glass, where we 
can exclusively examine the interaction between the material surface and the cells.    
Cellular viability and acute toxicity screening. To determine human cell viability 
following exposure to TMDs, we performed a fluorescence-based live-dead assay. 
HEK293f cells were exposed to ME-WS2, ME-MoS2 and CVD-MoS2 for various time 
intervals. Then cells were fluorescently labeled as live using calcein-acetoxymethyl 
(calcein AM) or dead using ethidium homodimer-1. Calcein AM passively crosses the 
cell membrane where it is converted into green fluorescent calcein by intracellular 
esterases in live cells (Bratosin, Mitrofan, Palii, Estaquier, & Montreuil, 2005). Ethidium 
homodimer-1 exclusively enters cells via damaged cell membranes and undergoes a 40-
fold enhancement of fluorescence when bound to nucleic acids in the nucleus of dead or 
dying cells (Skala et al., 2005). In Figure 4.2. (a)-(c), the green regions indicate living 
cells, while the red spots indicate the nuclei of dead cells. These images clearly show that 
the majority of HEK293f cells exposed to ME-WS2, ME-MoS2, and CVD-MoS2 after 24 
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hours are alive (green) and only a few cells have died (red), indicating that these TMDs 
in the mechanically exfoliated and CVD-grown forms are not acutely toxic to HEK293f 
cells. Over time, the percentage of surviving HEK293f cells increases if those cells are in 
contact with ME-WS2, ME-MoS2, CVD MoS2, PDMS, or graphite. In contrast, the 
percentage of surviving cells decreases when in contact with silver and remains low 
(~10%) when in contact with acutely toxic epoxy (Figure 4.2. (d)). HEK293f cells 
undergo mitosis at a rate of approximately once every 23 to 24 hours (Graham, Smiley, 
Russell, & Nairn, 1977), thus over a 48 hour time period cells should double twice. Due 
to the doubling rate, cells in contact with a biocompatible material show an increase in 
percentage of survivability. This result indicates that MoS2 and WS2 in these thin, large-
area forms are non-toxic. 
Cellular adhesion to transition-metal dichalcogenides. We investigated the nature of the 
interaction between cells and each material by scanning electron microscopy (SEM) 
imaging of HEK293f cells cultured for 24 hours in direct contact with either TMDs or 
epoxy as shown in Figure 4.3. The images on the left side (Figure 4.3. (a), (c), (e)) 
provide an overview of cells interacting with large surface areas of each material. The 
images on the right side (Figure 4.3. (b), (d), (f)) show a magnified view of HEK293f 
interaction with each material. In the case of ME-WS2, ME-MoS2, and CVD-MoS2, 
filopodia spread upon the surface of each respective material indicating good cellular 
adhesion and healthy cell morphology. Additionally, cells interact directly with each 
respective material, as observed directly by the presence and arrangement of filopodia. In 
contrast, in Figure 4.3. (g)-(h) cells up to 300 µm away from epoxy and in direct contact 
show the same rounded morphology, which indicates cellular toxicity. Observations 
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based on control materials, PDMS, graphite, and silver are provided in Figure 4.4. These 
comparison materials were chosen due to their range of biocompatibilities, from the very 
biocompatible graphite (G. Y. Chen et al., 2012) and PDMS (Łopacińska, Emnéus, & 
Dufva, 2013) to cytotoxic silver (de Lima, Seabra, & Durán, 2012) and acutely toxic 
epoxy. The observed interaction between HEK293f cells and TMDs indicates that not 
only cells are viable when exposed to TMDs but they thrive in contact with them. 
Oxidative stress assays. In biomedical implants, particulates are generated as the body 
breaks down implanted materials (Anderson, Rodriguez, & Chang, 2008), which can then 
infiltrate cells and interfere with basic cellular function. This process occurs by exposing 
the implant to a harsh, low pH environment; encapsulating it in proteins and eventually 
fibrous tissue; and surrounding it with macrophage cells that combine to form foreign 
body giant cells (Anderson et al., 2008). To investigate the potential for TMD-based 
particulates to influence cellular activities in the body, we produced micro- to nano-scale 
TMD particulates and measured their influence on HEK293f cells. We produced TMD 
particulates by applying ultrasonic agitation to crystals of WS2 and MoS2, and CVD-
grown MoS2. Histograms of particulate dimensions and representative SEM images of 
the particulates are shown in Figure 4.5. These particulates have average diameters of 
about 200-300 nm. As endocytosis typically occurs in particles that are smaller than 100 
nm (Jiang et al., 2008; Osman et al., 2012), the sizes of these particulates should prevent 
endocytosis. Additionally we evaluated ME-MoS2 particulates for surface charges using 
zeta potential. This allows us to evaluate cell viability risks due to surfaces charges. We 
found a surface charge of -22.87 ± 0.17 mV for ME-MoS2. Based on a previous study by 
Ayala et al., a negative surface charge should not interfere with either internal or external 
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cellular mechanisms (Ayala, Herrera, Latorre-Esteves, Toores-Lugo, & Rinaldi, 2013). 
By varying the volume of the solution-phase TMDs we added to the cell growth media, 
we were able to examine cellular viability after exposure to various concentrations of 
particulate TMDs. 
Materials that are not acutely toxic can still compromise cell viability by 
triggering oxidative stress, which commonly induces programmed cell death (apoptosis) 
(Circu & Aw, 2010). We exposed cells to particulates of TMDs and looked for an 
elevation in the amount of reactive oxygen species (ROS) using a proprietary cell-
permeable fluorogenic probe (Figure 4.6.). The fluorogenic probe is oxidized when 
interacting with ROS and then the oxidized form of the reagent binds to DNA and 
fluoresces (Elahi, Kong, & Matata, 2009). Therefore, the fluorescent intensity directly 
corresponds to the amount of ROS generated by the cells. We determined the 
fluorescence intensity as a measure of ROS level at various concentrations of particulate 
TMDs for multiple exposure times (Figure 4.7.) as well as for the flake/sheet forms of 
TMDs after 12 hours of exposure (Figure 4.8.). For comparison, we also used copper, a 
known generator of ROS, as a positive control (Alarifi, Ali, Verma, Alakhtani, & Ali, 
2013). A CVD MoS2 concentration of 100 µg/mL was not tested due to the difficulty in 
fabricating sufficient amounts of MoS2 via CVD to achieve that concentration. 
Additionally we attempted to track the TMD particulates via optical microscopy, but we 
did not detect any photoluminescence signals even in the TMD particulate samples before 
cellular exposure. This is likely because we have primarily multilayer particulates that 
have an indirect bandgap and do not emit photoluminescence (Splendiani et al., 2010). 
After, one hour of exposure to TMDs, there was no significant difference in fluorescence 
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intensity between the untreated cells, the cells exposed to TMD particulates, and the cells 
exposed to copper (Figure 4.7. (a)). However, after 8 hours of exposure to TMD 
particulates all concentrations and the untreated cells showed a significantly lower in 
fluorescence intensity from the ROS-generating copper control (Figure 4.7. (b)). 
Corresponding p-values in Figure 4.7. of these measurements are marked with * if they 
are less than 0.1 or ** if they are less than 0.05. After 12 hours of exposure to TMD 
flakes/sheets and PDMS cells showed significantly lower fluorescence intensity from the 
ROS-generating copper control (Figure 4.8.). After 24 hours of exposure to TMD 
particulates at all concentrations and untreated cells show a significant difference in 
fluorescence intensity from the ROS-generating copper control (Figure 4.7. (c)). 
Additionally we evaluated the viability of HEK293f cells after 48 hours exposure to 
particulates of ME-MoS2, and found that 98% of cells remained viable during this time 
period (Figure 4.9.). Measurements of ROS level show that particulates generated from 
ME-WS2, ME-MoS2 and CVD-MoS2 do not induce ROS, even in concentrations as high 
as 100 µg/mL, 100 μg/mL, and 10 μg/mL, respectively. Hence, the solution phase TMD 
particulates do not activate this pathway to programmed cell death, even after 24 hours 
exposure. 
Mutagenicity assays.  We evaluated the effect of TMD particulates on mutagenicity using 
Ames-fluctuation assays. The Ames assay employs strains of Salmonella typhimurium 
with loss-of-function mutations in the genes for histidine synthesis. When these strains 
gain the ability to grow in histidine-free environments, they must do so by acquiring 
compensatory mutations that enable them to regain histidine synthesis capability. 
Consequently, when the bacteria are exposed to a mutagen, a greater fraction of them will 
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acquire beneficial mutations and thrive without histidine. For this study, we used S. 
typhimurium tester strain TA100, which has a base-pair mutation, the most common type 
of genetic mutation. After 3 days exposure to various concentrations of TMD 
particulates, the TA100 bacterial strain showed no significant mutation as shown in 
Figure 4.10. A significantly lower percentage of revertants was observed in untreated and 
TMD particulate treated samples. Significance was determined using p-values (** if they 
are less than 0.1 or * if they are less than 0.05) calculated referencing the positive highly 
mutagenic control, sodium azide. This mutation assay yields a color change triggered by 
the growth of bacteria, in a non-histidine environment. Although, there was a low level of 
mutation that occurred for each TMD concentration, ranging from 5 to 25 % of the total 
replicates. This was anticipated because random mutation easily occurs in this bacterial 
strain, as 10 to 15% of untreated negative control samples regained histidine synthesis, as 
shown in Figure 4.11. Thus we can extrapolate that particulate TMDs are not a mutagenic 
agent for TA100, and therefore do not introduce base-pair substitutions. 
4.5. Discussion 
The results of the wide variety of assays we have conducted all point to the 
excellent biocompatibility of 2D TMDs towards mammalian tissue cells and bacteria. 
First, our live-dead assays showed no acute toxicity. Cells touching or in close proximity 
to the 2D TMDs show excellent survival, as shown in Figure 4.2. In contrast to other cell 
viability tests that rely on the conversion of extracellular dehydrogenases (Y. Li et al., 
2012), which can be influenced by the presence of nanoparticles (Woodruff et al., 2012), 
these fluorescence tests do not have that complication and are thus more suitable for 
evaluating nanostructured materials. In a previous study by Teo et al., lithiated forms of 
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WS2 and MoS2 are evaluated for biocompatibility, but these lithiated forms are 
fundamentally different than pristine TMDs in that they are metallic rather than 
semiconducting, and chemically quite different (Teo et al., 2014). In many potential 
biomedical applications for TMDs, we anticipate that the structural integrity, 
semiconducting electronic properties, and optical properties of pristine TMDs will be 
preferred over lithiated forms. 
Our evaluation of cell morphology with SEM imaging of HEK293f cells showed 
that the cells have excellent adhesion and interaction with the TMDs as indicated by the 
presence of multiple filopodia In contrast, known toxic materials yielded weak adhesion 
and rounded cells. The only other related study to our knowledge, Goldman et al., 
examined fullerene-like WS2 nanoparticles (Goldman et al., 2015), rather than 2D forms 
as we show here, which have very different physical properties. 
The ROS generation tests using nano-particulates showed that TMDs have far 
lower levels of ROS compared to copper, a known ROS generator, for several exposure 
times, as shown in Figure 4.7. We observed time-dependent changes in fluorescence due 
to ROS that likely indicate the time necessary for HEK293f cells to undergo apoptosis, 
which ranges from 6 to 9 hours (Mao et al., 2007). A previous study by Kou et al. using 
lithiated nanosheets of MoS2 also showed no significant generation of ROS (Kou et al., 
2014).  
Finally, since genetic modifications can lead to long-term health risks, we 
evaluated genotoxicity of TMD particulates using the Ames-fluctuation assay. If 
particulates are to induce genetic mutations, they are likely to do so by two mechanisms: 
(1) smaller particles can enter the cell and directly disrupt cellular activity, and (2) larger 
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particles can block and disrupt the function of porins, which are important for the transfer 
of materials into the cell. Since we have a range of particle sizes in our dispersions, it is 
conceivable to have both modes of genotoxicity. However, our results showed no 
significant genotoxicity for any of our 2D TMD preparations, as shown in Figure 4.10. 
Thus, we believe that the smaller particles are likely not being taken up into the cells at a 
significant rate, and that the larger particles are ineffective at blocking porins. 
4.6. Conclusions 
We have performed an extensive study of the biocompatibility of different 
pristine forms of the TMDs MoS2 and WS2. Our fluorescence-based live-dead assay, 
reactive oxygen species assay and mutagenic assay all strongly suggest that both 2D 
sheets and quasi-2D nano-particulates of WS2 and MoS2 are biocompatible and non-
mutagenic towards HEK293f human kidney cells and S. typhimurium TA100 bacteria, 
respectively. We found that the TMD materials did not trigger the generation of high 
levels of ROS that accompanies cell death. Even after prolonged exposure to 
concentrations as high as 100 μg/mL of TMDs, S. typhimurium bacteria did not 
significantly mutate. The results of our investigation pave the way for the use of 2D ME-
WS2, ME-MoS2, and CVD MoS2 in medical implantations, and highlights areas where 
additional investigations of biocompatibility will be important for adoption into implants 
and other biological systems. 
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Figure 4.1 Scanning electron microscopy images and Raman spectra. SEM images on 
left and Raman spectra on right (a) & (b) mechanically exfoliated few-layer WS2 (ME-
WS2), (c) & (d) few-layer ME-MoS2, and (e)&(f) chemical vapor deposition grown 
(CVD)-MoS2. 
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Figure 4.2.  Cellular viability assay showing fluorescence images of 
HEK293f cells in direct contact with TMD flakes/sheets. (a−c) Green color shows live 
cells and red color show dead cells. The panels are for (a) ME-WS2 (b) ME-MoS2, and 
(c) CVD-MoS2. (d) Overall cell viability of different control materials and different 
TMDs at as a function of time. 
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Figure 4.3.  Scanning electron microscopy images showing viable HEK293f cells 
adhered to (a, b) ME-WS2, (c, d) ME-MoS2, (e, f) CVD-MoS2, and (g, h) epoxy. The 
regions indicated by rectangles in the left panels are shown magnified in the right panels. 
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Figure 4.4.  Scanning electron microscopic images of control materials showing 
healthy cell morphology in the cases of graphite and PDMS and poor cell morphology in 
the case of silver. (a) & (b) HEK293f cells adhere to graphite flakes, (c) and (d) HEK293f 
cells adhere to PDMS substrate, (e) and (f) HEK293f cells adhere to sputtered silver 
substrate.  
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Figure 4.5.  Transition metal dichalcoginide particulates. (a, c, e) Histograms showing 
particulate diameters and (b, d, f) SEM images of representative particulates for (a, b) 
ME-WS2, (c, d) ME-MoS2, and (e, f) CVD-MoS2. 
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Figure 4.6.  Fluorescent images of HEK293f after exposure to various materials, (a, 
d, g) positive ROS inducing copper, (b, e, h) untreated cells, (c) ME-WS2, (f) ME-MoS2, 
and (i) CVD-MoS2.  
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Figure 4.7.  Fluorescence intensity plots measuring reactive oxygen species (ROS) 
generation for various TMD particulates and a copper positive control. TMD 
particulates do not generate significant levels of ROS after exposures of (a) 1, (b) 8, and 
(c) 24 hours. 
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Figure 4.8.  Fluorescence intensity plots measuring reactive oxygen species (ROS) 
generation for various TMD flakes/sheets, a copper positive control, and an 
untreated negative control. TMD flakes/sheets do not generate significant levels of 
ROS after 12 hours of exposure. 
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Figure 4.9.  Cellular viability assay showing fluorescence images of HEK293f cells in 
direct contact with particulates of ME-MoS2 (a) optical image of particulates in 
contact with HEK293f cells, (b) live cells stained with green fluorescent calcein AM, (c) 
dead cells stained with red fluorescent ethidium homodimer-1 and (d) merge of (a), (b) & 
(c) showing the overall viability of cells exposed to particulates of ME-MoS2. 
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Figure 4.10.  Mutagenicity measurement by Ames fluctuation test. The percentage of 
bacterial revertants after 3 days is calculated for positive controls of sodium azide, 
negative control of untreated bacteria, and varying concentrations of particulates of (a) 
ME-WS2, (b) ME-MoS2, and (c) CVD-MoS2. 
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Figure 4.11.  Ames-Fluctuation assay after exposure to controls and various 
concentrations of ME-WS2, ME-MoS2, and CVD-MoS2 showing that TMD particulates 
are non-mutagenic towards S. typhimurium TA100. 
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CHAPTER 5 
PHYSIOLOGICALLY AND BIOLOGICALLY REALISTIC EVALUATION OF AN 
ARTIFICIAL ARACHNOID GRANULATION COMPRISED OF HYDROGEL 
CHECK VALVES FOR THE TREATMENT OF HYDROCEPHALIC FLUID 
RETENTION  
5.1.  Abstract  
 Hydrocephalus is the leading cause of pediatric neurosurgery, as the current 
treatment requires the implantation of a shunt system to bypass cerebral spinal fluid 
(CSF) into the stomach. However, these shunt systems have a notoriously high failure 
rate, with 40 % of shunts failing within the first two years of implantation. Therefore, 
researchers have pursued alternate means of redirecting CSF flow within the cranium. 
Herein, is presented the evaluation of a fully realized, surgically friendly, passive implant 
to replace malfunctioning arachnoid granulations, the biological valves which naturally 
regulate the CSF flow pathway. Our artificial arachnoid granulation (aAG) is comprised 
of two hydrogel check valves encapsulated in a grommet structure. To aid in implantation 
and overall function aAG includes a removable puncture tool, a cone shape to wedge the 
dura mater apart, six suture points, and redundant hydrogel valves each with redundant 
CSF inlets. The hydrogel valves were individually evaluated in worst-case fluidic 
conditions emulating occlusion-modes in traditional shunts. Then the complete aAG was 
implanted in cadaver dura and evaluated in a cadaver bench-top model of hydrocephalus. 
Both individual valves and encapsulated valves remain within the design specifications 
for the relevant fluidic parameters, cracking pressure, hydraulic resistance, and reverse 
flow leakage. However, after prolonged evaluation an individual hydrogel check valve 
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failed to maintain the desired reverse flow leakage parameter. This provided a unique 
opportunity to investigate the potential failure modes for hydrogel check valves. After 
examining the valve via scanning electron microscopy, optical profilometry, and protein 
elution we determined that the failure mode was mechanical fatigue rather than 
occlusion, the most common failure mechanism for traditional shunts. This evaluation 
preliminarily validates the aAG as an alternative treatment for hydrocephalus paving the 
way for animal trials and subsequent human testing.   
5.2.  Introduction 
 Nearly 1 in every 500 infants born in the United States suffer from hydrocephalus 
(Pople, 2002). Hydrocephalus is characterized as a flaw in the cerebral spinal fluid (CSF) 
flow pathway (figure 5.1. (a)), which results in an accumulation of fluid in the brain. In 
healthy individuals, CSF is generated at a rate of 18 to 24 mL/hour by the ventricles 
(Zhu, Xenos, Linninger, & Penn, 2006). It then flows through and around the cerebral 
cortex providing nutrients and buoyancy and is drained through the arachnoid 
granulations, which act as one-way biological valves. In the case of hydrocephalic 
patients, this flow pathway is disrupted, either CSF cannot exit the ventricle—classified 
as non-communicating hydrocephalus—or CSF can exit the ventricle—communicating 
hydrocephalus—but is obstructed at a later point in the flow pathway, typically at the 
arachnoid granulations. Hydrocephalus affects brain development, can induce seizures, 
and if left untreated leads to death (Drake, Kestle, & Tuli, 2000).  
The current standard of care is the implantation of a shunt system (figure 5.1. (b)). 
These are implanted such that a short catheter, ventricular catheter, directs CSF from the 
ventricle through the skull into a regulating mechanism that controls CSF flow into a 
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second, longer catheter, distal catheter, which then directs CSF into distal organs. 
Unfortunately, these shunts have a notoriously high failure rate, where 40 % of shunts fail 
within the first two years of implantation (Drake et al., 2000) and 80% within 15 years 
(Stone, Walker, Jacobson, Phillips, & Silberstein, 2013). In the United States these 
failures are voluntarily reported to and classified by the Food and Drug Administration. 
Figure 5.1. (c) shows the failure mechanisms reported within the last 5 years, with the 
largest percentile nearly 18 % being occlusion-based, then breakage and leakage, 
respectively. The shunt system in figure 5.1. (d) was explanted after 12 years due to both 
tissue infiltration and breakage/leakage of the distal catheter. Of the mechanisms reported 
the most preventable are catheter based-occlusion failures. Occlusion normally divides 
into two general groups, based on the lifespan of implant (Hanak, Ross, Harris, Browd, & 
Shain, 2016). The act of implantation requires the destruction of tissue and the blood 
brain barrier. This leaves the implanted shunt in the presence of blood and cellular debris 
(C. A. Harris & Mcallister, 2012), both contain proteins that bind to the shunt inducing 
macrophages and monocytes to produce growth factors. These in turn attract astrocytes 
and can potentiate an inflammatory response (Moshayedi et al., 2014). This has been a 
common issue with ventricular catheters as simulated by Harris et al. (C. Harris et al., 
2015) and observed in explanted shunts (Hanak et al., 2016). While short term failure is 
generally more likely, long term failure can be equally devastating. While rare, cases of 
mineralization or calcification are often noted in long term studies of shunt failure. For 
example, Yamamoto et al. reported a small study with 12 patients, 3 of whom suffered 
from long term failure due to mineralization of the distal catheter (Yamamoto, Ohno, 
Aoyagi, Ichinose, & Hirakawa, 2002). They concluded that mechanical stress and the 
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addition of barium sulfate lead to catheter degradation and nucleation of mineral deposits, 
which ultimately induced a crack in the catheter (Yamamoto et al., 2002). Generally, 
occlusion-based shunt failures can be categorized based on implant lifespan with foreign 
body response, infection, and cellular growth resulting in short term failures and 
mechanical fatigue, mineralization, and calcification in long term ones. 
Therefore, numerous studies have been pursued to reduce flaws in shunt design, 
such as changing the surface properties of catheters to reduce cellular adhesion 
(Anderson, 2001) or the integration of proposed sensing elements to the system (Clark, 
Malpas, Mccormick, Heppner, & Budgett, 2015; B. J. Kim et al., 2016). Unfortunately, 
these modifications fail to address some of the underlying causes of occlusion, 
specifically, the large surface area for debris to accumulate. Thus, researchers have 
developed artificial arachnoid granulations (aAGs) to treat communicating 
hydrocephalus. These devices are inspired by arachnoid granulations to replicate the fluid 
dynamic capabilities. In vitro studies of explanted arachnoid granulation tissue, found 
that the differential pressure across the explanted tissue, i.e. cracking pressure, was 
approximately 39.5 mmH2O and the resulting flow rate was 269 µL/min. However, when 
the flow was reversed, the differential pressure was 44 mmH2O and the flow rate was 0 
µL/min, demonstrating the key fluid dynamic features of arachnoid granulations, a non-
zero cracking pressure and one-way fluid flow into the superior sagittal sinus (SSS) 
(Holman, Kurtcuoglu, & Grzybowski, 2010). 
Micro-electro-mechanical system (MEMS) based valves have been designed as 
aAGs, to establish and regulate one-way CSF flow from the subarachnoid space (SAS) 
into the SSS. In 2011, Oh et al. developed a 3-D dome petal perforated membrane based 
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aAG (Oh, Kim, Kralick, & Noh, 2011; Oh, Liu, Medina, Kralick, & Noh, 2014) and in 
2014 Schwerdt et al. designed a hydrogel check-valve based aAG (Schwerdt et al., 2015; 
Schwerdt, Bristol, & Chae, 2014). These designs both utilize perforated membranes to 
achieve unidirectional flow. The 3-D dome petal valve, however, does not have a non-
zero cracking pressure, i.e. the minimum differential pressure required to open the valve 
(Oh et al., 2011). The hydrogel check-valve design can vary cracking pressure based on 
the diameter of the inlet and range from 20 to 110 mmH2O which gives it a distinct 
advantage as healthy arachnoid granulations have a differential pressure of 39.5 mmH2O 
when fluid is passing through (Schwerdt et al., 2014). Additionally, the hydrogel check 
valve has been evaluated and found functionally equivalent to healthy arachnoid 
granulations and traditional shunts in terms of its transient hydrodynamic properties, lack 
of clogging and overtime performance (Schwerdt et al., 2015). However, the hydrogel 
check valve is only the functional component of the overall aAG, an encapsulating 
structure coined a grommet must be used to achieve a fully implantable device. The first 
iteration of this grommet was presented by Schwerdt et al. as a simple I-shape with a 
single hydrogel check valve enclosed (Schwerdt et al., 2015). This grommet was 12 mm 
in diameter, contained a single fluid inlet/outlet, and was evaluated for surgical viability. 
Unfortunately, it was found to be very difficult to place within the cadaver human brain 
and several potential failure points were identified.  
Herein, we report a fully-realized, surgically friendly aAG (figure 5.1. (e)-(g)) and 
its evaluation in a cadaver bench-top model of hydrocephalus, as well as continued 
evaluation of the aAG, functional component: the hydrogel check valve in increasingly 
realistic physiological and biological conditions. The aAG is designed as a replacement 
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of malfunctioning arachnoid granulations, so the schematic in figure 5.1. (e) shows the 
designated implantation location, at the longitudinal fissure, i.e. where arachnoid 
granulations are naturally found. Figure 5.1. (f) & (g) shows the removable puncture tool 
to aid in the implantation, which is integrated into the aAG to slice the dura mater, wedge 
the dura mater apart to insert the aAG and hold the aAG in place during suturing. This 
final iteration of the grommet structure is larger than the preliminary design, however it 
encapsulates two hydrogel check valves, provides four CSF inlets, six suture points, and a 
conical structure to aid in implantation. These hydrogel check valves utilize the same 
operating principle as reported by Schwerdt et al. where a perforated hydrogel membrane 
swells to seal a through silicon via and if sufficient differential pressure is applied the 
membrane deflects out-of-plane to allow CSF flow (Schwerdt et al., 2014). These 
hydrogel check valves were individually evaluated in a physiologically realistic spherical 
bench-top model of hydrocephalus. This is composed of a multi-directional flow pathway 
emulating the radius of curvature of the implantation location, longitudinal fissure where 
the SAS meets the SSS. Additionally, as protein and cellular adhesion to traditional 
shunts easily leads to occlusion (Sgouros & Dipple, 2004) and aAGs could also be 
susceptible to occlusion, we tested the hydrogel check valve in fluidic conditions which 
provide physiologically realistic concentrations of calcium, blood, fibronectin, and a 
combination of all three, in CSF extracted from hydrocephalus patients and maintained at 
internal body temperature ~ 37 °C during evaluation. These evaluations showed that the 
hydrogel check valve maintains functionality in each condition, with the hydraulic 
resistance maintaining within the specifications of traditional shunt systems and the 
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reverse flow leakage maintaining well below the maximum allowable leakage flow rate 
of 50 µL/min (Czosnyka, Czosnyka, Whitehouse, & Pickard, 1997).  
After valve functionality was established under these stringent conditions, a valve 
was encapsulated in the grommet structure and placed into a cadaver model of 
hydrocephalus. This cadaver model uses sheep cerebral cortex and dura mater to emulate 
the desired implant location, in the dura mater regulating CSF flow from the SAS to the 
SSS, while still allowing for the measurement of differential pressure across the aAG and 
flow out of the aAG. The aAG in the cadaver model shows near identical flow vs. 
differential pressure characteristics with an above zero cracking pressure and little to no 
reverse flow leakage. The cadaver model does not truly replicate the SSS, as there is no 
perpendicular blood flow at the outlets of the grommet, therefore we constructed a 
simulated SSS matching the dimensions, blood flow and viscosity to evaluate the flow 
around the grommet structure post-implantation. The blood-mimicking fluid spiked with 
both fluorescent and non-fluorescent 10 µm beads show flow evenly dividing at the cone 
structure and coming back together after the grommet. While the aAG maintained design 
specifications during cadaver testing, in valve testing after nearly 3 months the valve 
failed to maintain less than 50 µL/min reverse flow leakage. This gave us a unique 
opportunity to examine the failure mechanism of this hydrogel check valve and compare 
it to the commonly found failure modes in traditional shunts. We examined the valve 
using scanning electron microscopy, and optical profilometry and similar valves using 
protein elution. While we did observe adsorbed blood cells, cellular debris, biofilm 
formation, and were able to elute albumin from the valve, this did not contribute to 
overall valve failure. Instead this was attributed to mechanical fatigue of the hydrogel as 
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seen by a crack at the center of the hydrogel structure. This information provides valuable 
insights into improving the hydrogel check valve by optimizing the hydrogel layer for 
robustness and incorporating coatings to decrease cellular and protein adsorption. 
Ultimately, we have developed an aAG which is capable of accurately replicating the 
function of arachnoid granulations in a variety of in vitro models of hydrocephalus 
increasing in both biologically and physiologically realistic conditions. 
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5.3.  Material and Methods 
Fabrication of silicon-based hydrogel check valve. The fabrication of the silicon-based 
hydrogel check valve was performed using MEMS manufacturing technology, following 
the protocol developed by Schwerdt et al. (Schwerdt et al., 2015; Schwerdt et al., 2014). 
Briefly, we began with a clean silicon wafer, chemical vapor deposition is used to deposit 
~100 nm of silicon dioxide and then parylene is thermally deposited, ~100 nm. This layer 
was then patterned using O2 plasma and submerged ~12 hours in a pH adjusted hydrogel 
adhesion promoting solution of γ-methacryloxypropyltrimethoxysilane then rinsed with 
water and baked at 100°C for at least 1 hour. The hydrogel solution was prepared; the 
base 2-hydroxyethyl methacrylate, crosslinker ethylene glycol dimethacrylate and 
photoinitiator 2,2-dimethoxy-2-phenylacetophenone mixed at a ratio of 1 to 0.04 to 0.1 
respectively. This solution was poured onto the prepared wafer with the aid of a spacer to 
define the thickness of the resulting hydrogel layer which was simultaneously UV 
crosslinked and patterned at ~ 400 mJ/cm2. Backside alignment is then used to define the 
inlet dimensions and prepare for deep reactive ion etching. Through silicon etching is 
completed when the silicon dioxide is visible. Then the silicon dioxide and parylene are 
each etched using hydrofluoric acid and O2 plasma respectively. And the wafer is 
submerged in water for at least 12 hours to prepare for evaluation.  
Fabrication of the artificial arachnoid granulation. The artificial arachnoid granulation 
(aAG) is comprised of three elements, two hydrogel check valves encapsulated within a 
grommet structure. After ascertaining valve functionality, two valves are then infilled 
with water soluble wax and placed within a custom steel mold. Uncured 
polydimethylsiloxane (PDMS) mixed with crosslinker at a ratio of 10:1 is poured into the 
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mold. The mold is then degassed for approximately two minutes until all air bubbles are 
removed from the structure and then left to cure at room temperature for 24 to 48 hours. 
When the PDMS has fully cured, the mold is cracked open and the resulting aAG 
structure is submerged in ~45°C water to remove the wax, re-hydrate the hydrogel 
membrane, and prepare for functional evaluation.  
Construction of the spherical bench-top model of hydrocephalus. The bench top model of 
hydrocephalus was constructed using a two-piece spherical mold with an interior 
diameter of approximately 6.4 cm. This closely approximates the radius of curvature at 
the longitudinal fissure where SSS and SAS meet, as shown in figure 5.1. (e). Four short 
lengths of tubing, diameter 5 mm, was added to the spherical mold, 3 on piece A and the 
last on the piece B, and a water tight seal was formed using a combination of PDMS and 
epoxy, as shown in figure 5.2. To fill the spherical set up the tubing in part B was filled 
with the desired fluid and then the rest of part B was filled. Then a hydrogel check valve 
was inserted in the interior of the left section of tubing on part A and back filled with 
fluid and connected to part B. Using the remaining two tubing sections the sphere was 
filled with the desired fluid. After the tubing was filled with fluid a pressure sensor was 
connected to ~ cm away from the fluidic chamber and the rest was sealed. The tubing 
connected to part B was then connected to a syringe pump (Harvard Apparatus Pump 33). 
Finally, the section of tubing with the hydrogel was connected via a Y shaped tubing 
connector to the pressure sensor and a down stream flow sensor. 
Calibration of sensors. Two pressure sensors (Omega PX26-005DV) were used in this 
set up, however one of them was configured as a flow sensor using different calibration 
methods. Calibrating the pressure sensor required a vertical column and data acquisition 
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board (National Instruments NI USB 6216), one side of the sensor was connected to the 
bottom of the vertical column and various amounts of water was added to it. The voltage 
at each water level was recorded as well as the height in mm of the water level. Minimum 
of five different water levels were recorded to draw a statistically viable trend line, the 
equation of which was used as the conversion from sensor voltage output to differential 
pressure. The flow sensor was calibrated in a similar manner, using a linear regression. 
The flow sensor was connected to a syringe pump, a data acquisition board, and 
connected across a 35 cm length of 500 µm diameter tubing such that the flow could be 
determined based on the differential pressure across a known fluidic resistance. Eight 
different flow rates were used to calibrate the sensor in both forward and reverse flow 
and the voltage at each flow rate was recorded giving a linear trend line, the equation of 
which was used as the conversion from sensor voltage output to flow rate. 
Evaluation of hydrogel check valve in the spherical bench-top model of hydrocephalus. 
The hydrogel check valve was first evaluated for basic functionality in the spherical 
setup. This pass/fail test ensured two things, that the valve would open under forward 
flow and that the reverse flow leakage was less than 50 µL/min. Pass/fail testing was 
performed in the spherical setup with water. Initially, the syringe pump was set to 
forward flow at a rate of 100 µL/min. After the flow rate stabilized the syringe pump was 
stopped and stabilized. Then flow was reversed at a rate of -25 µL/min continuing to 
decrease flow in 25 µL/min intervals until a reverse flow of -200 µL/min was achieved. 
During this testing the absolute value of the differential pressure across the valve should 
continuously increase indicating that the valve is closed and not leaking. After a valve 
passes initial testing a full characterization is performed to establish valve characteristics 
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such as cracking pressure. Characterization is performed using the spherical set up and 
various fluids at either room temperature or internal body temperature ~37°C. Similar to 
the pass/fail testing, the syringe pump is initially set to forward flow at a rate of 100 
µL/min and after the flow was stabilized it is decreased then stabilized in 25 µL/min 
intervals until zero flow. After flow is stopped it is then reversed at a rate of -25 µL/min 
continuing to decrease flow in 25 µL/min intervals until a reverse flow of -200 µL/min 
was achieved, then flow is set to -100 µL/min and then flow is stopped. Then a forward 
flow of 25 µL/min is set and increased in 25 µL/mi intervals until a forward flow of 100 
µL/min is achieved. During characterization if flow leakage was observed and had a 
leakage rate of higher than 50 µL/min the valve was considered defective. The closing of 
the valve resulted in an increase of differential pressure between the interior of the 
spherical set up and the tubing representing the superior sagittal sinus. Additionally, a 
Medtronic PS Medical Strata II valve was obtained and tested under the same protocol as 
the hydrogel check valve in order to establish a comparison of fluidic characteristics in 
each fluid. 
Cerebrospinal fluid preparation. CSF from male and female hydrocephalic patients was 
collected with institutional review board approval at Phoenix Children’s Hospital. 
Samples were maintained in a 4°C environment when not in use. Five CSF solutions 
were generated from an aggregate of patient CSF, four of which were spiked with various 
additives known to generate occlusions in traditional shunts: final concentration of 1.1 
mM calcium, 7.5 µg/mL fibronectin, 5% blood, and all three, calcium, fibronectin, and 
blood.  
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Construction of the cadaver bench-top model of hydrocephalus. The cadaver bench-top 
model was built from a clear union PVC fitting and sheep cadaver cerebral cortex and 
dura mater tissues (figure 5.3.). Dura mater was removed from the sheep brain and placed 
between the two sections of the PVC union fitting, a water tight seal was formed between 
the respective sides of the union with a differential pressure sensor measuring pressure 
across the dura mater. With the water tight seal confirmed, the structure was then 
disassembled and the aAG was sutured into the dura mater (figure 5.4.) and further 
secured using surgical glue as recommended. The structure was carefully reassembled 
with a cylindrical section of cerebral cortex tissue placed at the inlet of the aAG and filled 
with patient CSF making sure air was fully removed from the set up. The cerebral cortex 
side of the set-up was then connected to an unfilled water column while the other side 
was connected to a pre-calibrated flow sensor and a reservoir to maintain a pressure 
equilibrium during testing.   
Evaluation of artificial arachnoid granulation in the cadaver bench-top model of 
hydrocephalus. As the valves within the aAG were established as functional via the 
previously described pass/fail testing. Testing the aAG began with a stable near zero 
differential pressure with the CSF level in the column matching the height of the aAG. 
CSF was added to the column in 5 mm height intervals with at least one minute of 
stabilization time before adding more CSF until a forward flow rate of at least 200-300 
µL/min was achieved. CSF was then drained from the column and the cadaver bench-top 
model was reversed to evaluate reverse flow leakage. Again, we began with the CSF 
level in the column matching the height of the aAG and then increase it in 5 mm height 
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intervals until a differential pressure of 300 mmH2O was achieved. This was repeated at 
least two times.  
Evaluation of flow around the artificial Arachnoid Granulation in a simulated superior 
sagittal sinus. We fabricated a simulated superior sagittal sinus setup reflecting the 
dimensions of the SSS. This was achieved using by curing PDMS in a custom 3D printed 
mold. The pre-fabricated aAG was inserted into the simulated superior sagittal sinus 
setup. This set up was then filled with a water/glycerol solution, at a ratio of 16:9, which 
matches the dynamic viscosity of blood with various concentrations of both fluorescent 
and non-fluorescent beads. Beads flowed at a rate of 0.3 L/min matching the anticipated 
flow rate in the superior sagittal sinus (Hirabuki et al., 2000) and were recorded. The 600 
images taken during fluorescent testing were stacked and aggregated to show the flow 
pattern just below the tip of the grommet structure. And 100 of the images taken during 
non-fluorescent testing were divided into 5 columns with a width of 315 µm and beads 
were tallied within each column of the 4.4 mm2 field of view.  
Scanning electron microscopy. After the hydrogel check valves failed, due to excessive 
reverse flow leakage they were dried and then prepared for scanning electron 
microscopy. The valve was sputter coated with a layer of gold, approximately 10 nm 
thick, and imaged using a scanning electron microscope (Hitachi S-4700-II). 
Elution of the hydrogel check valve, protein identification via electrophoresis and 
Bradford protein concentration assay. CSF spiked with all three additives at realistic 
physiological concentrations was flowed through the hydrogel check valves at 200 
µL/min for 72 hours at 37°C using a peristaltic pump (Harvard Apparatus). The valves 
were washed with TBS (50 mM Tris-HCl pH 7.4 and 150 mM NaCl) at a rate of 200 
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µL/min for 1 hour. Valves were fragmented, then incubated in 500 µL of 4X SDS 
loading buffer (40% v/v glycerol, 240 mM Tris-HC) pH 6.8, 8% wt/v sodium dodecyl 
sulfate (SDS), 0.04% bromophenol blue, 5% β-mercaptoethanol) at 75°C for 10 minutes, 
electrophoresed with multiple loadings *Sheen et al* on a 3% stacking/6% resolving SDS 
polyacrylamide gel and stained with coomassie (Bio-Rad). 
5.4.  Results 
The aAG is composed of two components, i.e. hydrogel check valves, 
encapsulated by a passive grommet structure. The grommet structure is designed to aid 
surgeons with device implantation. Schwerdt et al. introduced a preliminary 12 mm I-
shaped grommet (Schwerdt et al., 2015). Here, we present a 24 mm cone shaped 
grommet (figure 5.5. (a)), which encapsulates two hydrogel check valves, provides four 
CSF inlets, six suture points, and a conical structure to aid in implantation (figure 5.5. (b) 
& (c)). As demonstrated by Schwerdt et al. the hydrogel check valves capitalize on the 
“fully-passive” swelling of a perforated hydrogel membrane to achieve a non-zero 
cracking pressure and little to no reverse flow leakage. Swelling of the hydrogel 
effectively seals the inlet until sufficient differential pressure is applied, where the 
differential pressure becomes greater than the intrinsic cracking pressure, PT, of the valve 
(figure 5.5. (d)) (Schwerdt et al., 2014). Figure 5.5. (e) & (f) shows scanning electron 
microscopy images of the outlet, i.e. tethered hydrogel membrane (e) and the inlet, i.e. 
through silicon via (f). The inset image of the valve inlet shows the texture at the walls of 
the via, while this texture ranges from 2 to 5 microns it should not provide purchase for 
cellular growth. 
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Prior to evaluating the full aAG, we evaluated the hydrogel check valves, in 
physiologically realistic bench-top model of hydrocephalus. In order to more accurately 
evaluate valves, we developed a physiological representation of the implantation location, 
at the longitudinal fissure where the SAS meets the SSS. This spherical bench-top setup 
(figure 5.6. (a) and figure 5.2.) emulates the radius of curvature at the interface of the two 
hemispheres of the brain and generates the resulting multi-directional fluid flow 
anticipated at the inlet of the hydrogel check valve. By comparison the proof-of-concept 
testing model was a purely linear flow pathway into the valve inlet (Schwerdt et al., 
2015). Similar valve fluidic parameters (figure 5.6. (b) & (c)) were found. However, the 
time to obtain stabile flow in the spherical set up was greater, >5 min, than in the linear 
flow setup. This difference in time was likely due to the larger fluid volume in the 
spherical set up, approximately 5 times greater at 200 mL, which would more slowly 
translate changes in the flow rate. Aside from this delay, the change from linear inlet flow 
to multi-directional inlet flow did not affect the functionality of the hydrogel check valve 
showing that under physiologically realistic flow patterns the valve operated within the 
design specifications. 
To further emulate realistic patient conditions, we developed a series of 
biologically realistic fluids all based on CSF with various additives known to generate 
occlusion-based failures in traditional shunts (figure 5.7.). The hydrogel check valve 
maintained functionality, without a reverse flow leakage greater than 50 μL/min, for a 
total of 89 days, while being testing under six fluid conditions: CSF at room temperature 
~23°C, CSF at internal body temperature ~ 37°C, CSF at 37°C spiked with calcium 
(1.1mM), CSF at 37°C spiked with blood (5% v/v), CSF at 37°C spiked with fibronectin 
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(7.5μg/mL) and CSF at 37°C spiked with all three additives. The respective 
concentrations for each additive was based on concentrations from studies analyzing CSF 
of patients (Jones & Keep, 1988; Rutter & Smales, 1976; Schutzer et al., 2010; Torre et 
al., 1991). These fluid conditions were chosen to replicate surgical, foreign body, and 
long-term implantation conditions. An FDA approved Medtronic PS Medical Strata II 
shunt was tested in identical conditions to the hydrogel check valve. Both show very 
similar fluidic characteristics. As shown in figure 5.6. (b), the hydrogel check valve 
performs within the same parameters, namely cracking pressure ~40 mmH2O (figure 5.6. 
(b) inset), as the Medtronic Strata II shunt in the worst-case condition of CSF at 37°C 
spiked with all three additives. Showing that in the spherical bench-top model of 
hydrocephalus the hydrogel check valve has nearly identical fluidic characteristics as a 
FDA approved traditional shunt system. Furthermore, the average hydraulic resistance, 
169.8 ± 47 mmH2O/mL/min, and reverse flow leakage, 6.97 ± 3.7 µL/min, under all 
fluidic conditions remained within or below, respectively, the establish parameter for 
traditional shunt systems (figure 5.6. (c)) (Czosnyka et al., 1997). 
After establishing valve functionality in both a physiologically and biologically 
realistic environment we encapsulated the valve into a grommet structure. This was then 
sutured into cadaver dura mater and inserted into a second bench-top model of 
hydrocephalus, which employs cadaver cerebral cortex in addition to dura mater and 
allows for measurement of both differential pressure across the aAG and the flow out of 
the aAG (figure 5.3. and figure 5.8. (a)). The fluidic characteristics of the aAG were 
measured using CSF maintained at ~37 °C (figure 5.8. (b)). The inset of figure 5.8. (b) 
shows a cracking pressure of ~15 mmH2O for the overall aAG in the cadaver setup.  
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In order to evaluate the impact of implanting the aAG in the designated location, 
we also developed a bench-top model of the SSS (figure 5.8. (c)). This model matches the 
interior dimensions of the SSS space as well as the blood viscosity and flow. The blood 
emulating fluid was spiked with both fluorescent and non-fluorescent 10 µm diameter 
particles to evaluate the resulting SSS blood flow pattern post-implantation of the aAG. 
Figure 5.8. (d) shows a stacked and aggregated image of fluorescent particles over time, 
where particles initially impact one side of the cone fluid then bifurcates at the tip and 
reconnects after the structure. This pattern is confirmed by tallying the number of non-
fluorescent particles in regions B-F for 100 images taken during a physiologically 
realistic flow rate of 0.3 L/min (Hirabuki et al., 2000). 
After ensuring a viable implantation location, long term valve testing was 
performed in various fluidic conditions (figure 5.6. (c)). After 89 days the valve failed to 
remain within design specifications by having an above 50 µL/min reverse flow leakage. 
This provided us with a unique opportunity to explore the failure mechanisms of this 
valve and extrapolate methods to counter these failure modes. Scanning electron 
microscopy was performed (figure 5.9. (a) & (b)) to establish gross analysis. Two 
observations prompted further investigation, as shown in (a) at the dashed line there 
appears to be a change in the hydrogel structure and the dashed box indicated the region 
in (b) at the base of the hydrogel tethers showing the accumulation of biological debris or 
the growth of a biofilm. Therefore, we exposed a valve to continuous worst-case fluidic 
conditions for 72 hours and then eluted the proteins which adsorbed to the valve surface 
(figure 5.10.). Proteins from the eluent were isolated using SDS-PAGE and found to be 
below the threshold for detection, 50 ng of protein. This was then repeated using the 
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eluent from 5 valves (figure 5.9. (c)) and a single band appeared at approximately 67 kD, 
which corresponds to albumin. However, the aggregation of debris would not necessarily 
account for the increase in reverse flow leakage. Therefore, we investigated the abnormal 
surface feature found in figure 5.9. (a) using optical profilometry to determine if the 
structure could be a crack in the hydrogel (figure 5.9. (d)). We determined that this 
feature was indeed a crack that could be associated with mechanical fatigue of the 
hydrogel layer. This crack would permit reverse flow leakage under elevated reverse 
pressures. 
5.5.  Discussion 
Despite the recent improvements in traditional shunt systems, with the 
augmentation of internal surfaces (Anderson, 2001) as well as the proposed integration of 
sensing elements (Clark et al., 2015; B. J. Kim et al., 2016). Commercial shunts still 
suffer from a notoriously high failure rate where 40% of implanted shunts fail within the 
first two years of use (Drake et al., 2000) and 80% within the first 15 years (Stone et al., 
2013). There are numerous failure modes that have been identified and tracked by the 
FDA, with the leading causes of shunt explanation being occlusion, breakage, and 
leakage (figure 5.1. (c)). As these shunt systems artificially bypass the natural, brain-
contained CSF flow pathway to redirect CSF into the stomach, researchers have long 
sought ways to reintegrate CSF flow within the brain (Aschoff et al., 1999). One such 
concept, a ventriculosinus shunt also known as the el-shafei shunt, redirects CSF from the 
ventricle into the SSS. While this has been attempted in human hydrocephalus patients, it 
is more effective for a niche subset of patients i.e. non-congenital adult hydrocephalus 
patients. Infant growth has been shown to interfere with ventriculosinus shunts overtime 
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(Toma, Tarnaris, Kitchen, & Watkins, 2010). MEMS researchers have further refined this 
concept for a greater subset of patients, those who suffer from communicating 
hydrocephalus. Employing micro-scale valves to regulate flow directly from the SAS to 
the SSS, acting as aAGs.  
In healthy individuals, the arachnoid granulations act as one-way biological 
valves to regulate CSF flow from the SAS to the SSS (figure 5.1. (a)). Arachnoid 
granulations have two key fluidic characteristics, a one-way fluid flow and a non-zero 
cracking pressure. Explanted healthy arachnoid granulation tissue, shows a forward flow 
rate of up to 269 µL/min and a cracking pressure of approximately 39.5 mmH2O 
(Holman et al., 2010). These parameters give a baseline for the design of micro-scale 
valves, which act as aAGs. Traditional shunt systems also provide a guideline for these 
characteristics having a cracking pressure range of 10 to 230 mmH2O (Hirabuki et al., 
2000). Two micro-scale valve concepts have been pursued as aAGs, a 3D dome petal 
valve (Oh et al., 2011) and a hydrogel check valve (Schwerdt et al., 2014). The 3D dome 
petal concept achieved little to no reverse flow leakage under a differential pressure of ~ 
200 mmH2O, however it was unable to achieve a non-zero cracking pressure, as the 
valve opened under approximately zero applied pressure (Oh et al., 2011). The hydrogel 
check valve capitalized on the inherent swelling of a perforated hydrogel membrane to 
achieve both a non-zero cracking pressure, 20-110 mmH2O, and little to no reverse flow 
leakage with an applied differential pressure of greater than 800 mmH2O (Schwerdt et 
al., 2014). Neither of these first iterations concepts were implantable designs rather 
valves which approximated the function of arachnoid granulations. 
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Subsequently, the 3D dome petal concept was integrated into a micro-needle array 
for ease of implantation in the dura mater, to regulate flow from the SAS to the SSS (Oh 
et al., 2014). Preliminary evaluation of the implantable micro-needle array showed its 
ability to puncture cadaver dura mater and the short-term adhesion of blood platelets (Oh 
et al., 2014). However, the valve fluidic characteristics, i.e. cracking pressure and reverse 
flow leakage, were not evaluated in this secondary containment vessel and the 
preliminary evaluations were only performed for a duration of one hour despite the 
intended long-term use of the device. The hydrogel check valve was also integrated into a 
containment vessel, i.e. an I-shaped PDMS grommet structure, with a single hydrogel 
valve encapsulated within it (Schwerdt et al., 2015). As with the 3D dome petal valve 
integrated into a micro-needle array, the hydrogel valve was not functionally evaluated 
after encapsulation within the grommet structure.  
Both the micro-needle array and the I-shaped grommet have distinct advantages 
as implants. The micro-needle array is easily placed in the dura mater, as titanium coated 
needles can puncture the dura without deformation. However, methods of long-term 
fixation of the micro-needle array such as suturing or surgical glue were not discussed, as 
the array is tapered this may allow for loosening of the fixation over time. Additionally, 
mechanical compliance between the implant and the dura mater is also a concern. The 
Young’s modulus of SU8 is in the range of 4 GPa (T. Xu et al., 2016), and the modulus 
of PDMS is 0.548 to 3.728 MPa depending on crosslinking ratios (Z. Wang, Volinsky, & 
Gallant, 2014), while the modulus of human dura mater is in the range of 65 to 105 MPa 
(Runza et al., 1999). Often, drastic differences in implant stiffness or implant density 
(SU8 1,200, Ti 4,506, PDMS 965, and cerebral cortex 1,045 kg/m3) can lead to glial scar 
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formation (Lind, Linsmeier, & Schouenborg, 2013). Despite the mechanical compliance 
of the I-shaped PDMS grommet being closer to that of dura mater, the implantation 
protocol for the I-shaped grommet is significantly more complex, requiring an incision of 
the dura mater before the inserting the grommet and affixing it via suturing (Schwerdt et 
al., 2015). Our iteration of the grommet structure, the aAG, (figure 5.5. (a)-(c)) 
incorporates concepts from both the micro-needle array and the I-shaped grommet. The 
aAG incorporates redundancy, similar to micro-needle array, by having two hydrogel 
check valves encapsulated within one structure, additionally redundancy is achieved by 
having two CSF inlets per valve. Additionally, the aAG is designed to be surgically 
friendly with the cone shape and inclusion of a puncture tool, (figure 5.1. (f) & (g), to 
easily puncture the dura mater and wedge it open to insert the aAG. Also, the puncture 
tool aids in affixing the aAG by holding it in place during suturing and the application of 
surgical glue. Furthermore, the aAG is made of mechanically compliant PDMS to match 
the stiffness of the dura mater.  
To evaluate the effects of implanting the aAG into the SSS, we developed a 
simulated SSS setup based on the interior SSS. Blood emulating water spiked with 
fluorescent and non-fluorescent microbeads flowed around the tip of the grommet 
generating the flow pattern shown in figure 5.8. (a). Images were aggregated to 
demonstrate the flow over time and non-fluorescent beads were quantified by tallying the 
number of beads per column to show the symmetry of flow at the tip of the implanted 
aAG, where bead bifurcate around the grommet tip. While the concept of an artificial 
device which mimics the cracking pressure and flow parameters of arachnoid 
granulations is relatively novel, the desire to directly drain CSF into the SSS was 
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presented as early as 1896 (Aschoff et al., 1999). In practice the closest device to realize 
this goal is the El-Shafei shunt, a non-regulated flow pathway artificially generated 
between the ventricle and SSS (Toma et al., 2010). Both our proposed aAG and the El-
Shafei shunt intrude into the SSS, with respective protruding volumes of 176 mm3 and 
171 mm3 and surface areas of 256 mm2 and 528 mm2. As the El-Shafei concept with a 
similar protruding volume and surface area has not lead to cases of thrombosis we can 
hypothesize that the aAG would also follow this trend.  
The aAG is not simple a grommet structure, it contains two functional 
components, hydrogel check valves, which replicate the fluid dynamic characteristics of 
arachnoid granulations. Therefore, these must also be evaluated individually. Throughout 
testing in a physiologically realistic bench-top model of hydrocephalus (figure 5.6. (a)), 
these devices remained within design specifications over the course of 89 days of testing 
using a wide range of fluidic conditions known to induce failure in traditional shunt 
systems. Traditional shunt systems have a cracking pressure range of 10 to 230 mmH2O, 
a fluidic resistance range of 13.5 to 340 mmH2O/mL/min and a maximum reverse flow 
leakage of 50 µL/min (Hirabuki et al., 2000). The hydrogel check valve tested in the wide 
range of fluidic conditions has an average cracking pressure of 24.1 ± 3.4 mmH2O, 
fluidic resistance of 169.7 ± 47 mmH2O/mL/min and a reverse flow leakage of 6.9 ± 3.7 
µL/min (figure 5.6. (c) and figure 5.11.). These three valve fluidic characteristics are all 
well aligned and within the specifications for traditional shunt systems. Additionally, 
industry standards such as ISO 7197 and ASTM F647 designate specific pressure and 
flow characteristics for example an acceptable shunt is evaluated in terms of reverse flow 
leakage by applying a differential pressure of at least 300 mmH2O and monitoring the 
126 
resulting leakage of less than 100 µL/min, ASTM F647 6.2.3.2. The hydrogel check 
valve is placed under similar differential pressures and achieves a reverse flow leakage of 
less than 50 µL/min indicating that the valve leakage rate is lower even than the 
allowable range for traditional shunts.  
Furthermore, when the valve is encapsulated into the grommet structure it further 
maintains design specifications. This testing was performed using the cadaver-based 
bench-top model of hydrocephalus (figure 5.3. and figure 5.8. (a)). This second bench-top 
model was designed to not only allow for functional testing of the hydrogel check valves 
encapsulated by the grommet but to test the validity of the redundant CSF inlets. 
Comparing pre- and post-encapsulation the cracking pressure of the valve decreased from 
70 mmH2O to 19.5 mmH2O, however this remains within the desired cracking pressure 
range and pre-encapsulation testing was performed at room temperature with water, while 
post-encapsulation testing was performed at internal body temperature ~ 37°C with 
patient CSF. The cadaver bench-top model also included cadaver cerebral cortex material 
(figure 5.8. (a)) to represent the SAS. Often in patients with hydrocephalus the cerebral 
cortex tissue swells placing it directly in contact with the dura mater. To avoid aAG 
blockage due to cerebral cortex swelling, alternate CSF inlets were incorporated parallel 
to the cerebral cortex tissue (figure 5.5. (c)). In functional testing of the aAG CSF flow 
was unobstructed by the presence of free-floating cadaver cerebral cortex tissues. 
Therefore, the aAG maintained functionality within a realistic cadaver bench-top model 
of hydrocephalus.  
While the valve did remain within design specifications while encapsulated by the 
grommet structure, however, in individual testing it eventually failed by exceeding a 
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reverse flow rate of 50 µL/min. This provided a unique opportunity to isolate, 
understand, and compare failure modes between the hydrogel check valves and 
traditional shunt systems. As previous studies have found with conventional shunts, bio-
films and cellular debris tend to adsorb to the surface of hydrocephalus shunts and can 
induce failure (Brydon et al., 1998). The amount and identity of these proteins and 
cellular debris indicate foreign body response or sensitization. Specific proteins, such as 
fibronectin, are known to attract astrocyte and glial cells to the surface of shunts inducing 
and proliferating foreign body response (Brydon et al., 1998; VandeVord et al., 2004). 
Therefore, we performed scanning electron microscopy to investigate the valve surface 
looking for cellular debris, material accumulation or other features which could indicate a 
valve failure mode (figure 5.9.). Gross SEM imagery identified the accumulation of 
debris and a hydrogel surface feature which could both have caused the increase in 
reverse flow leakage.  
Therefore, we performed two assessments to isolate the failure mechanism. First, 
we emulated the testing conditions by continuously flowing worst-case CSF at ~37°C for 
72 hours, eluted the proteins adsorbed on the surface of the hydrogel check valve, and 
performed a standard SDS- polyacrylamide gel electrophoresis assay, as shown in figure 
5.10. While CSF is a protein-rich solution, examination of the CSF solution spiked with 
all three additives had an expected band at 220 kDa corresponding to the molecular mass 
of fibronectin. However, the most prominent band in the CSF sample corresponds to the 
highly abundant albumin protein, 67 kDa. Protein eluted from a single hydrogel check 
valve incubated for 72 hours in CSF spiked with all three additives was below our 
threshold for detection, approximately 100 ng of protein (figure 5.10.). To overcome this, 
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we increased the number of devices to five hydrogel check valves, figure 5.9. (c). The 
eluted protein from the combined five devices had a single band at 67 kDa, 
corresponding to the overwhelming abundant albumin protein from the CSF solution 
(Schutzer et al., 2010). Albumin protein has been previously reported to adsorb to 
hydrocephalus shunts (Brydon et al., 1998). With a total mass of merely 1 μg adsorbed to 
5 devices, as found using a Bradford protein concentration assay, 200 ng per a device on 
average, few proteins appear to have adsorbed to the surface of the hydrogel. This further 
supports that protein adsorption to the surface of the hydrogel check valve did not 
significantly contribute to device failure. 
Therefore, we further investigated the abnormal surface feature of the hydrogel 
(figure 5.12.). This was further investigated in detail using optical profilometry, figure 
5.9. (d) and found that this deformation was at two different heights indicating a crack in 
the hydrogel. This crack would permit reverse flow leakage under elevated reverse 
pressures. This may have resulted from structural weakness in the relatively thin hydrogel 
layer of merely 100 μm after prolonged testing. Repeated testing of at least 8 replicates 
where the applied force on the hydrogel is at least 0.577 mN forcing the malleable 
hydrogel into sharp edge of the significantly stiffer silicon substrate beneath the hydrogel 
may have caused this crack formation. There are numerous ways to address this 
mechanical fatigue-based failure mode, increasing the thickness of the hydrogel, 
optimizing the structural properties of the hydrogel, or exchanging the silicon substrate 
for a more compliant, yet, biocompatible polymer. These are all promising avenues to 
pursue. As each new iteration of the aAG is developed modes of failure must also be 
considered, it is reassuring that the traditional shunt failure mode of occlusion was not 
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present, likely due the significantly reduced surface area of the aAG when compared to 
traditional shunts.   
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Figure 5.1. Cerebrospinal fluid flow and hydrocephalus, including current and 
proposed treatments.  (a) Schematic of cerebrospinal fluid flow (CSF) in normal brains, 
where CSF is produced at the ventricles (~18-24 mL/hour) it flows through and around 
the cerebral cortex and is drained out of the arachnoid granulations into the superior 
sagittal sinus. (b) In hydrocephalus this pathway is obstructed, the current treatment is the 
implantation of a shunt system (inset). Shunts are highly prone to failure, a breakdown of 
failure mode as reported to the FDA within the last 5 years is shown (c). (d) Explanted 
shunt after 12 years of use with breakage of the distal catheter and occlusion on the valve 
mechanism. (e-g) Proposed implantation location and images of an artificial arachnoid 
granulation (aAG) designed to replace shunt systems. 
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Figure 5.2.  The spherical testing setup to mimic the desired implant location.  (a) 
Image of the overall testing setup where a syringe pump flows CSF into a sphere (b) 
maintained at body temperature ~37°C and the differential pressure across the valve and 
the flow rate out of the valve are monitored.   
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Figure 5.3.  Cadaver bench-top model of hydrocephalus. (a) overall image of cadaver 
bench top model testing for reverse flow leakage with the simulated superior sagittal 
sinus (SSS) towards the CSF pressure column. (b) artificial arachnoid granulation sutured 
into cadaver dura mater for testing. 
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Figure 5.4.  Artificial arachnoid granulation sutured into cadaver dura mater. (a) 
front view, i.e. SSS side of the aAG sutured into dura mater with both outlets 
unobstructed. (b) back view, i.e. SAS side of the aAG sutured into dura mater with 6 
suture points and 4 CSF inlets.  
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Figure 5.5. Artificial arachnoid granulation overall dimensions and implementation 
with hydrogel check valve operating principle and scanning electron microscopy. (a) 
Dimensions of the artificial arachnoid granulation (aAG). (b) front view, i.e. SSS side of 
the aAG showing the outlets, suture points and hydrogel check valves. (c) back view, i.e. 
SAS side of the aAG showing main and alternate CSF inlets. (d) Schematic 
demonstrating the operating principle of the hydrogel check valve, where the valve 
remains closed until the differential pressure ΔP becomes greater than the cracking 
pressure PT it then opens allowing fluid to flow exclusively from the subarachnoid space 
to the superior sagittal sinus. (e)&(f) scanning electron microscopy images of (e) 
hydrogel valve outlet and (f) through silicon via inlet, with inset image showing the 
texture of the through silicon via.   
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Figure 5.6.  Hydrogel check valve operation in the spherical bench-top model of 
hydrocephalus. (a) Schematic of the spherical bench-top model. (b) Differential pressure 
vs. flow characteristics of the hydrogel check valve and a traditional shunt in the worst 
case fluidic condition, CSF spiked with physiological concentrations of blood, 
fibronectin, and calcium and maintained at ~37°C. (c) Hydraulic resistance and reverse 
flow leakage of a single hydrogel check valve during 89 days of testing under various 
fluidic conditions. 
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Figure 5.7. Differential pressure vs flow characteristics of a hydrogel check valve 
and a traditional shunt under various fluidic conditions. (a) CSF at room temperature, 
~23°C. (b) CSF at body temperature, ~37°C. (c) CSF at body temperature, ~37°C, spiked 
with 1.1mM calcium. (d) CSF at body temperature, ~37°C, spiked with 5% blood. (e) 
CSF at body temperature, ~37°C, spiked with 7.5 μg/mL fibronectin. (f) CSF at body 
temperature, ~37°C, spiked with 1.1mM calcium, 5% blood, and 7.5 μg/mL fibronectin. 
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Figure 5.8. aAG testing in a cadaver bench-top model of hydrocephalus and a 
simulated SSS.  (a) schematic of the cadaver bench-top model of hydrocephalus to 
monitor differential pressure and flow of the aAG. (b) fluidic characteristics of the overall 
aAG in the cadaver model with the inset showing the cracking pressure of the aAG. (c) 
schematic of the aAG inside the simulated SSS model. (d) Compilation of 600 images 
taken while fluid matching the viscosity of blood spiked with 10 μm fluorescent beads 
flows around the grommet structure at a rate of 0.3 L/min. (e) Quantification of the 
number of beads relative to grommet position over 100 images.  
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Figure 5.9.  Failure mechanism exploration. Scanning electron microscopy of (a) the 
overall valve after 89 days of testing and (b) the area between two tethers indicated by a 
square in (a). (c) Electrophoresis of protein elution from an aggregate of 5 valves exposed 
to worst case fluidic conditions for 72 hours. (d) Optical profilometry of the line 
indicated in (a) showing a crack in the hydrogel.  
142 
 
 
Figure 5.10.  Electrophoresis of protein elution of a single hydrogel check valve.  
Protein aggregation after 72 hours of exposure to worst case fluidic conditions was not 
above the threshold for detection for sodium dodecyl sulfate polyacrylamide gel 
electrophoresis. 
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Figure 5.11.  Cracking pressure under various conditions. Cracking pressure of a 
single hydrogel check valve under a wide variety of conditions known to induce 
occlusion in traditional shunt systems. Green box highlights the acceptable cracking 
pressure range for traditional shunt systems, 10 to 230 mmH2O.  
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Figure 5.12.  Detailed failure mechanism exploration. Scanning electron microscopy 
of the surface feature determined to be a crack in the hydrogel membrane.  
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